Minnesota 2025-2026 Regular Session

Minnesota House Bill HF1615 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1		1.1 A bill for an act
2		-	1.2 relating to cannabis; modifying provisions regarding the sale of cannabinoids
3		-	1.3 derived from hemp; modifying medical cannabis provisions; modifying cannabis
4		-	1.4 business provisions; modifying the limits of delta-9 tetrahydrocannabinol in edible
5		-	1.5 cannabinoid products and lower-potency hemp edibles when intended to be
6		-	1.6 consumed as beverages; amending Minnesota Statutes 2024, sections 151.72,
7		-	1.7 subdivisions 3, 5a; 152.22, subdivisions 4, 7, 10, 13; 152.24; 152.25; 152.26;
8		-	1.8 152.261; 152.27, subdivisions 2, 7; 152.28, subdivisions 1, 3; 152.29, subdivisions
9		-	1.9 1, 2, 3a, 4; 152.31; 152.32, subdivision 2; 152.33, subdivisions 1a, 4; 152.35;
10		-	1.10 152.37; 342.01, subdivisions 9, 34, 47, 48, 50, 71, by adding subdivisions; 342.02,
11		-	1.11 subdivision 3; 342.09, subdivision 2; 342.10; 342.11; 342.12; 342.13; 342.14,
12		-	1.12 subdivisions 1, 3, 6; 342.151, subdivisions 2, 3; 342.17; 342.18, subdivision 2;
13		-	1.13 342.22, subdivision 3, by adding a subdivision; 342.28, subdivisions 1, 8; 342.29,
14		-	1.14 subdivisions 1, 7; 342.30, subdivision 1; 342.32, subdivisions 1, 4, 5; 342.33,
15		-	1.15 subdivision 1; 342.34, subdivision 5; 342.36, subdivision 6; 342.37, by adding
16		-	1.16 subdivisions; 342.39, subdivision 3; 342.43, subdivisions 1, 2, by adding a
17		-	1.17 subdivision; 342.44, subdivision 1; 342.45, by adding subdivisions; 342.46,
18		-	1.18 subdivisions 1, 3, 4, 5, 6, 7, 9, by adding subdivisions; 342.51, subdivision 2, by
19		-	1.19 adding a subdivision; 342.515, subdivisions 1, 5; 342.52, subdivision 9, by adding
20		-	1.20 a subdivision; 342.57; 342.59, subdivision 2; 342.61, subdivision 4; 342.62,
21		-	1.21 subdivision 2; 342.63, subdivisions 2, 3, 5, 6; 342.65; 342.66, subdivision 6;
22		-	1.22 proposing coding for new law in Minnesota Statutes, chapter 342; repealing
23		-	1.23 Minnesota Statutes 2024, sections 152.22, subdivision 2; 342.151, subdivision 1;
24		-	1.24 342.36, subdivision 5.
25		-	1.25BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
26		-	1.26 ARTICLE 1
27		-	1.27 MEDICAL CANNABIS
28		-	1.28 Section 1. Minnesota Statutes 2024, section 152.22, subdivision 4, is amended to read:
29		-	1.29 Subd. 4.Health care practitioner."Health care practitioner" means a Minnesota licensed
30		-	1.30Minnesota-licensed doctor of medicine, a Minnesota licensed Minnesota-licensed physician
31		-	1.31assistant acting within the scope of authorized practice, or a Minnesota licensed
32		-	1Article 1 Section 1.
33		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT
	2	+	1.2 relating to cannabis; modifying the limits of delta-9 tetrahydrocannabinol in edible
	3	+	1.3 cannabinoid products and lower-potency hemp edibles when intended to be
	4	+	1.4 consumed as beverages; amending Minnesota Statutes 2024, sections 151.72,
	5	+	1.5 subdivision 5a; 342.01, subdivision 50; 342.46, subdivision 6.
	6	+	1.6BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
	7	+	1.7 Section 1. Minnesota Statutes 2024, section 151.72, subdivision 5a, is amended to read:
	8	+	1.8 Subd. 5a.Additional requirements for edible cannabinoid products.(a) In addition
	9	+	1.9to the testing and labeling requirements under subdivisions 4 and 5, an edible cannabinoid
	10	+	1.10must meet the requirements of this subdivision.
	11	+	1.11 (b) An edible cannabinoid product must not:
	12	+	1.12 (1) bear the likeness or contain cartoon-like characteristics of a real or fictional person,
	13	+	1.13animal, or fruit that appeals to children;
	14	+	1.14 (2) be modeled after a brand of products primarily consumed by or marketed to children;
	15	+	1.15 (3) be made by applying an extracted or concentrated hemp-derived cannabinoid to a
	16	+	1.16commercially available candy or snack food item;
	17	+	1.17 (4) be substantively similar to a meat food product; poultry food product as defined in
	18	+	1.18section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision
	19	+	1.197;
	20	+	1.20 (5) contain an ingredient, other than a hemp-derived cannabinoid, that is not approved
	21	+	1.21by the United States Food and Drug Administration for use in food;
	22	+	1Section 1.
	23	+	REVISOR BD/MI 25-0413902/19/25
34	24		State of Minnesota
35	25		This Document can be made available
36	26		in alternative formats upon request
37	27		HOUSE OF REPRESENTATIVES
38	28		H. F. No. 1615
39		-	NINETY-FOURTH SESSION
40		-	Authored by Stephenson02/26/2025
41		-	The bill was read for the first time and referred to the Committee on Commerce Finance and Policy
42		-	Adoption of Report: Amended and re-referred to the Committee on Ways and Means04/07/2025 2.1Minnesota-licensed advanced practice registered nurse who has an active license in good
43		-	2.2standing and the primary responsibility for the care and treatment of the qualifying medical
44		-	2.3condition of a person an individual diagnosed with a qualifying medical condition.
45		-	2.4 Sec. 2. Minnesota Statutes 2024, section 152.22, subdivision 7, is amended to read:
46		-	2.5 Subd. 7.Medical cannabis manufacturer."Medical cannabis manufacturer" or
47		-	2.6"manufacturer" means an entity registered by the commissioner office to cultivate, acquire,
48		-	2.7manufacture, possess, prepare, transfer, transport, supply, or dispense medical cannabis,
49		-	2.8delivery devices, or related supplies and educational materials.
50		-	2.9 Sec. 3. Minnesota Statutes 2024, section 152.22, subdivision 10, is amended to read:
51		-	2.10 Subd. 10.Patient registry number."Patient registry number" means a unique
52		-	2.11identification number assigned by the commissioner office to a patient enrolled in the registry
53		-	2.12program.
54		-	2.13 Sec. 4. Minnesota Statutes 2024, section 152.22, subdivision 13, is amended to read:
55		-	2.14 Subd. 13.Registry verification."Registry verification" means the verification provided
56		-	2.15by the commissioner office that a patient is enrolled in the registry program and that includes
57		-	2.16the patient's name, registry number, and, if applicable, the name of the patient's registered
58		-	2.17designated caregiver or parent, legal guardian, or spouse.
59		-	2.18 Sec. 5. Minnesota Statutes 2024, section 152.24, is amended to read:
60		-	2.19 152.24 FEDERALLY APPROVED CLINICAL TRIALS.
61		-	2.20 The commissioner office may prohibit enrollment of a patient in the registry program
62		-	2.21if the patient is simultaneously enrolled in a federally approved clinical trial for the treatment
63		-	2.22of a qualifying medical condition with medical cannabis. The commissioner office shall
64		-	2.23provide information to all patients enrolled in the registry program on the existence of
65		-	2.24federally approved clinical trials for the treatment of the patient's qualifying medical condition
66		-	2.25with medical cannabis as an alternative to enrollment in the patient registry program.
67		-	2.26 Sec. 6. Minnesota Statutes 2024, section 152.25, is amended to read:
68		-	2.27 152.25 COMMISSIONER OFFICE DUTIES.
69		-	2.28 Subdivision 1.Medical cannabis manufacturer registration.(a) The commissioner
70		-	2.29office shall register two in-state manufacturers for the production of all medical cannabis
71		-	2.30within the state. A registration agreement between the commissioner office and a
72		-	2Article 1 Sec. 6.
73		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 3.1manufacturer is nontransferable. The commissioner office shall register new manufacturers
74		-	3.2or reregister the existing manufacturers by December 1 every two years, using the factors
75		-	3.3described in this subdivision. The commissioner office shall accept applications after
76		-	3.4December 1, 2014, if one of the manufacturers registered before December 1, 2014, ceases
77		-	3.5to be registered as a manufacturer. The commissioner's office's determination that no
78		-	3.6manufacturer exists to fulfill the duties under sections 152.22 to 152.37 is subject to judicial
79		-	3.7review in Ramsey County District Court. Data submitted during the application process are
80		-	3.8private data on individuals or nonpublic data as defined in section 13.02 until the
81		-	3.9manufacturer is registered under this section. Data on a manufacturer that is registered are
82		-	3.10public data, unless the data are trade secret or security information under section 13.37.
83		-	3.11 (b) As a condition for registration, a manufacturer must agree to:
84		-	3.12 (1) begin supplying medical cannabis to patients by July 1, 2015; and
85		-	3.13 (2) comply with all requirements under sections 152.22 to 152.37.
86		-	3.14 (c) The commissioner office shall consider the following factors when determining
87		-	3.15which manufacturer to register:
88		-	3.16 (1) the technical expertise of the manufacturer in cultivating medical cannabis and
89		-	3.17converting the medical cannabis into an acceptable delivery method under section 152.22,
90		-	3.18subdivision 6;
91		-	3.19 (2) the qualifications of the manufacturer's employees;
92		-	3.20 (3) the long-term financial stability of the manufacturer;
93		-	3.21 (4) the ability to provide appropriate security measures on the premises of the
94		-	3.22manufacturer;
95		-	3.23 (5) whether the manufacturer has demonstrated an ability to meet the medical cannabis
96		-	3.24production needs required by sections 152.22 to 152.37; and
97		-	3.25 (6) the manufacturer's projection and ongoing assessment of fees on patients with a
98		-	3.26qualifying medical condition.
99		-	3.27 (d) If an officer, director, or controlling person of the manufacturer pleads or is found
100		-	3.28guilty of intentionally diverting medical cannabis to a person other than allowed by law
101		-	3.29under section 152.33, subdivision 1, the commissioner office may decide not to renew the
102		-	3.30registration of the manufacturer, provided the violation occurred while the person was an
103		-	3.31officer, director, or controlling person of the manufacturer.
104		-	3Article 1 Sec. 6.
105		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 4.1 (e) The commissioner office shall require each medical cannabis manufacturer to contract
106		-	4.2with an independent laboratory to test medical cannabis produced by the manufacturer. The
107		-	4.3commissioner office shall approve the laboratory chosen by each manufacturer and require
108		-	4.4that the laboratory report testing results to the manufacturer in a manner determined by the
109		-	4.5commissioner office.
110		-	4.6 Subd. 1a.Revocation or nonrenewal of a medical cannabis manufacturer
111		-	4.7registration.If the commissioner office intends to revoke or not renew a registration issued
112		-	4.8under this section, the commissioner office must first notify in writing the manufacturer
113		-	4.9against whom the action is to be taken and provide the manufacturer with an opportunity
114		-	4.10to request a hearing under the contested case provisions of chapter 14. If the manufacturer
115		-	4.11does not request a hearing by notifying the commissioner office in writing within 20 days
116		-	4.12after receipt of the notice of proposed action, the commissioner office may proceed with
117		-	4.13the action without a hearing. For revocations, the registration of a manufacturer is considered
118		-	4.14revoked on the date specified in the commissioner's office's written notice of revocation.
119		-	4.15 Subd. 1b.Temporary suspension proceedings.The commissioner office may institute
120		-	4.16proceedings to temporarily suspend the registration of a medical cannabis manufacturer for
121		-	4.17a period of up to 90 days by notifying the manufacturer in writing if any action by an
122		-	4.18employee, agent, officer, director, or controlling person of the manufacturer:
123		-	4.19 (1) violates any of the requirements of sections 152.22 to 152.37 or the rules adopted
124		-	4.20thereunder;
125		-	4.21 (2) permits, aids, or abets the commission of any violation of state law at the
126		-	4.22manufacturer's location for cultivation, harvesting, manufacturing, packaging, and processing
127		-	4.23or at any site for distribution of medical cannabis;
128		-	4.24 (3) performs any act contrary to the welfare of a registered patient or registered designated
129		-	4.25caregiver; or
130		-	4.26 (4) obtains, or attempts to obtain, a registration by fraudulent means or misrepresentation.
131		-	4.27 Subd. 1c.Notice to patients.Upon the revocation or nonrenewal of a manufacturer's
132		-	4.28registration under subdivision 1a or implementation of an enforcement action under
133		-	4.29subdivision 1b that may affect the ability of a registered patient, registered designated
134		-	4.30caregiver, or a registered patient's parent, legal guardian, or spouse to obtain medical cannabis
135		-	4.31from the manufacturer subject to the enforcement action, the commissioner office shall
136		-	4.32notify in writing each registered patient and the patient's registered designated caregiver or
137		-	4.33registered patient's parent, legal guardian, or spouse about the outcome of the proceeding
138		-	4.34and information regarding alternative registered manufacturers. This notice must be provided
139		-	4Article 1 Sec. 6.
140		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 5.1two or more business days prior to the effective date of the revocation, nonrenewal, or other
141		-	5.2enforcement action.
142		-	5.3 Subd. 2.Range of compounds and dosages; report.The office shall review and publicly
143		-	5.4report the existing medical and scientific literature regarding the range of recommended
144		-	5.5dosages for each qualifying condition and the range of chemical compositions of any plant
145		-	5.6of the genus cannabis that will likely be medically beneficial for each of the qualifying
146		-	5.7medical conditions. The office shall make this information available to patients with
147		-	5.8qualifying medical conditions beginning December 1, 2014, and update the information
148		-	5.9every three years. The office may consult with the independent laboratory under contract
149		-	5.10with the manufacturer or other experts in reporting the range of recommended dosages for
150		-	5.11each qualifying medical condition, the range of chemical compositions that will likely be
151		-	5.12medically beneficial, and any risks of noncannabis drug interactions. The office shall consult
152		-	5.13with each manufacturer on an annual basis on medical cannabis offered by the manufacturer.
153		-	5.14The list of medical cannabis offered by a manufacturer shall be published on the Office of
154		-	5.15Cannabis Management website.
155		-	5.16 Subd. 3.Deadlines.The commissioner office shall adopt rules necessary for the
156		-	5.17manufacturer to begin distribution of medical cannabis to patients under the registry program
157		-	5.18by July 1, 2015, and have notice of proposed rules published in the State Register prior to
158		-	5.19January 1, 2015.
159		-	5.20 Subd. 4.Reports.(a) The commissioner office shall provide regular updates to the task
160		-	5.21force on medical cannabis therapeutic research and to the chairs and ranking minority
161		-	5.22members of the legislative committees with jurisdiction over health and human services,
162		-	5.23public safety, judiciary, and civil law Cannabis Advisory Council under section 342.03
163		-	5.24regarding: (1) any changes in federal law or regulatory restrictions regarding the use of
164		-	5.25medical cannabis or hemp; and (2) the market demand and supply in this state for products
165		-	5.26made from hemp that can be used for medicinal purposes.
166		-	5.27 (b) The commissioner office may submit medical research based on the data collected
167		-	5.28under sections 152.22 to 152.37 to any federal agency with regulatory or enforcement
168		-	5.29authority over medical cannabis to demonstrate the effectiveness of medical cannabis for
169		-	5.30treating a qualifying medical condition.
170		-	5Article 1 Sec. 6.
171		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 6.1 Sec. 7. Minnesota Statutes 2024, section 152.26, is amended to read:
172		-	6.2 152.26 RULEMAKING.
173		-	6.3 (a) The commissioner office may adopt rules to implement sections 152.22 to 152.37.
174		-	6.4Rules for which notice is published in the State Register before January 1, 2015, may be
175		-	6.5adopted using the process in section 14.389.
176		-	6.6 (b) The commissioner office may adopt or amend rules, using the procedure in section
177		-	6.714.386, paragraph (a), to implement the addition of dried raw cannabis as an allowable form
178		-	6.8of medical cannabis under section 152.22, subdivision 6, paragraph (a), clause (4). Section
179		-	6.914.386, paragraph (b), does not apply to these rules.
180		-	6.10 Sec. 8. Minnesota Statutes 2024, section 152.261, is amended to read:
181		-	6.11 152.261 RULES; ADVERSE INCIDENTS.
182		-	6.12 (a) The commissioner of health office shall adopt rules to establish requirements for
183		-	6.13reporting incidents when individuals who are not authorized to possess medical cannabis
184		-	6.14under sections 152.22 to 152.37 are found in possession of medical cannabis. The rules
185		-	6.15must identify professionals required to report, the information they are required to report,
186		-	6.16and actions the reporter must take to secure the medical cannabis.
187		-	6.17 (b) The commissioner of health office shall adopt rules to establish requirements for law
188		-	6.18enforcement officials and health care professionals to report incidents involving an overdose
189		-	6.19of medical cannabis to the commissioner of health office.
190		-	6.20 (c) Rules must include the method by which the commissioner office will collect and
191		-	6.21tabulate reports of unauthorized possession and overdose.
192		-	6.22 Sec. 9. Minnesota Statutes 2024, section 152.27, subdivision 2, is amended to read:
193		-	6.23 Subd. 2.Office duties.(a) The office shall:
194		-	6.24 (1) give notice of the program to health care practitioners in the state who are eligible
195		-	6.25to serve as health care practitioners and explain the purposes and requirements of the
196		-	6.26program;
197		-	6.27 (2) allow each health care practitioner who meets or agrees to meet the program's
198		-	6.28requirements and who requests to participate, to be included in the registry program to
199		-	6.29collect data for the patient registry;
200		-	6.30 (3) provide explanatory information and assistance to each health care practitioner in
201		-	6.31understanding the nature of therapeutic use of medical cannabis within program requirements;
202		-	6Article 1 Sec. 9.
203		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 7.1 (4) create and provide a certification to be used by a health care practitioner for the
204		-	7.2practitioner to certify whether a patient has been diagnosed with a qualifying medical
205		-	7.3condition;
206		-	7.4 (5) supervise the participation of the health care practitioner in conducting patient
207		-	7.5treatment and health records reporting in a manner that ensures stringent security and
208		-	7.6record-keeping requirements and that prevents the unauthorized release of private data on
209		-	7.7individuals as defined by section 13.02;
210		-	7.8 (6) develop safety criteria for patients with a qualifying medical condition as a
211		-	7.9requirement of the patient's participation in the program, to prevent the patient from
212		-	7.10undertaking any task under the influence of medical cannabis that would constitute negligence
213		-	7.11or professional malpractice on the part of the patient; and
214		-	7.12 (7) conduct research and studies based on data from health records submitted to the
215		-	7.13registry program and submit reports on intermediate or final research results to the legislature
216		-	7.14and major scientific journals. The office may contract with a third party to complete the
217		-	7.15requirements of this clause. Any reports submitted must comply with section 152.28,
218		-	7.16subdivision 2.
219		-	7.17 (b) The office may add a delivery method under section 152.22, subdivision 6, upon a
220		-	7.18petition from a member of the public or the Cannabis Advisory Council under section 342.03
221		-	7.19or as directed by law. If the office wishes to add a delivery method under section 152.22,
222		-	7.20subdivision 6, the office must notify the chairs and ranking minority members of the
223		-	7.21legislative policy committees having jurisdiction over health and public safety of the addition
224		-	7.22and the reasons for its addition, including any written comments received by the office from
225		-	7.23the public and any guidance received from the Cannabis Advisory Council under section
226		-	7.24342.03, by January 15 of the year in which the office wishes to make the change. The change
227		-	7.25shall be effective on August 1 of that year, unless the legislature by law provides otherwise.
228		-	7.26 Sec. 10. Minnesota Statutes 2024, section 152.27, subdivision 7, is amended to read:
229		-	7.27 Subd. 7.Notice requirements.Patients and registered designated caregivers shall notify
230		-	7.28the commissioner office of any address or name change within 30 days of the change having
231		-	7.29occurred. A patient or registered designated caregiver is subject to a $100 fine for failure
232		-	7.30to notify the commissioner office of the change.
233		-	7Article 1 Sec. 10.
234		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 8.1 Sec. 11. Minnesota Statutes 2024, section 152.28, subdivision 1, is amended to read:
235		-	8.2 Subdivision 1.Health care practitioner duties.(a) Prior to a patient's enrollment in
236		-	8.3the registry program, a health care practitioner shall:
237		-	8.4 (1) determine, in the health care practitioner's medical judgment, whether a patient suffers
238		-	8.5from a qualifying medical condition, and, if so determined, provide the patient with a
239		-	8.6certification of that diagnosis;
240		-	8.7 (2) advise patients, registered designated caregivers, and parents, legal guardians, or
241		-	8.8spouses who are acting as caregivers of the existence of any nonprofit patient support groups
242		-	8.9or organizations;
243		-	8.10 (3) provide explanatory information from the office to patients with qualifying medical
244		-	8.11conditions, including disclosure to all patients about the experimental nature of therapeutic
245		-	8.12use of medical cannabis; the possible risks, benefits, and side effects of the proposed
246		-	8.13treatment; the application and other materials from the office; and provide patients with the
247		-	8.14Tennessen warning as required by section 13.04, subdivision 2; and
248		-	8.15 (4) agree to continue treatment of the patient's qualifying medical condition and report
249		-	8.16medical findings to the office.
250		-	8.17 (b) Upon notification from the office of the patient's enrollment in the registry program,
251		-	8.18the health care practitioner shall:
252		-	8.19 (1) participate in the patient registry reporting system under the guidance and supervision
253		-	8.20of the office;
254		-	8.21 (2) report health records of the patient throughout the ongoing treatment of the patient
255		-	8.22to the office in a manner determined by the commissioner office and in accordance with
256		-	8.23subdivision 2;
257		-	8.24 (3) determine, every three years, if the patient continues to suffer from a qualifying
258		-	8.25medical condition and, if so, issue the patient a new certification of that diagnosis; and
259		-	8.26 (4) otherwise comply with all requirements developed by the office.
260		-	8.27 (c) A health care practitioner may utilize telehealth, as defined in section 62A.673,
261		-	8.28subdivision 2, for certifications and recertifications.
262		-	8.29 (d) Nothing in this section requires a health care practitioner to participate in the registry
263		-	8.30program.
264		-	8Article 1 Sec. 11.
265		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 9.1 Sec. 12. Minnesota Statutes 2024, section 152.28, subdivision 3, is amended to read:
266		-	9.2 Subd. 3.Advertising restrictions.(a) A health care practitioner shall not publish or
267		-	9.3cause to be published any advertisement that:
268		-	9.4 (1) contains false or misleading statements about medical cannabis or about the medical
269		-	9.5cannabis registry program;
270		-	9.6 (2) uses colloquial terms to refer to medical cannabis, such as pot, weed, or grass;
271		-	9.7 (3) states or implies the health care practitioner is endorsed by the Department of Health
272		-	9.8office or by the medical cannabis registry program;
273		-	9.9 (4) includes images of cannabis in its plant or leaf form or of cannabis-smoking
274		-	9.10paraphernalia; or
275		-	9.11 (5) contains medical symbols that could reasonably be confused with symbols of
276		-	9.12established medical associations or groups.
277		-	9.13 (b) A health care practitioner found by the commissioner office to have violated this
278		-	9.14subdivision is prohibited from certifying that patients have a qualifying medical condition
279		-	9.15for purposes of patient participation in the registry program. The commissioner's office's
280		-	9.16decision that a health care practitioner has violated this subdivision is a final decision of
281		-	9.17the commissioner office and is not subject to the contested case procedures in chapter 14.
282		-	9.18 Sec. 13. Minnesota Statutes 2024, section 152.29, subdivision 1, is amended to read:
283		-	9.19 Subdivision 1.Manufacturer; requirements.(a) A manufacturer may operate eight
284		-	9.20distribution facilities, which may include the manufacturer's single location for cultivation,
285		-	9.21harvesting, manufacturing, packaging, and processing but is not required to include that
286		-	9.22location. The commissioner office shall designate the geographical service areas to be served
287		-	9.23by each manufacturer based on geographical need throughout the state to improve patient
288		-	9.24access. A manufacturer shall not have more than two distribution facilities in each
289		-	9.25geographical service area assigned to the manufacturer by the commissioner office. A
290		-	9.26manufacturer shall operate only one location where all cultivation, harvesting, manufacturing,
291		-	9.27packaging, and processing of medical cannabis shall be conducted. This location may be
292		-	9.28one of the manufacturer's distribution facility sites. The additional distribution facilities
293		-	9.29may dispense medical cannabis and medical cannabis products but may not contain any
294		-	9.30medical cannabis in a form other than those forms allowed under section 152.22, subdivision
295		-	9.316, and the manufacturer shall not conduct any cultivation, harvesting, manufacturing,
296		-	9.32packaging, or processing at the other distribution facility sites. Any distribution facility
297		-	9.33operated by the manufacturer is subject to all of the requirements applying to the
298		-	9Article 1 Sec. 13.
299		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 10.1manufacturer under sections 152.22 to 152.37, including, but not limited to, security and
300		-	10.2distribution requirements.
301		-	10.3 (b) A manufacturer may acquire hemp grown in this state from a hemp grower, and may
302		-	10.4acquire hemp products produced by a hemp processor. A manufacturer may manufacture
303		-	10.5or process hemp and hemp products into an allowable form of medical cannabis under
304		-	10.6section 152.22, subdivision 6. Hemp and hemp products acquired by a manufacturer under
305		-	10.7this paragraph are subject to the same quality control program, security and testing
306		-	10.8requirements, and other requirements that apply to medical cannabis under sections 152.22
307		-	10.9to 152.37 and Minnesota Rules, chapter 4770.
308		-	10.10 (c) A medical cannabis manufacturer shall contract with a laboratory approved by the
309		-	10.11commissioner office, subject to any additional requirements set by the commissioner office,
310		-	10.12for purposes of testing medical cannabis manufactured or hemp or hemp products acquired
311		-	10.13by the medical cannabis manufacturer as to content, contamination, and consistency to
312		-	10.14verify the medical cannabis meets the requirements of section 152.22, subdivision 6. The
313		-	10.15cost of laboratory testing shall be paid by the manufacturer.
314		-	10.16 (d) The operating documents of a manufacturer must include:
315		-	10.17 (1) procedures for the oversight of the manufacturer and procedures to ensure accurate
316		-	10.18record keeping;
317		-	10.19 (2) procedures for the implementation of appropriate security measures to deter and
318		-	10.20prevent the theft of medical cannabis and unauthorized entrance into areas containing medical
319		-	10.21cannabis; and
320		-	10.22 (3) procedures for the delivery and transportation of hemp between hemp growers and
321		-	10.23manufacturers and for the delivery and transportation of hemp products between hemp
322		-	10.24processors and manufacturers.
323		-	10.25 (e) A manufacturer shall implement security requirements, including requirements for
324		-	10.26the delivery and transportation of hemp and hemp products, protection of each location by
325		-	10.27a fully operational security alarm system, facility access controls, perimeter intrusion
326		-	10.28detection systems, and a personnel identification system.
327		-	10.29 (f) A manufacturer shall not share office space with, refer patients to a health care
328		-	10.30practitioner, or have any financial relationship with a health care practitioner.
329		-	10.31 (g) A manufacturer shall not permit any person to consume medical cannabis on the
330		-	10.32property of the manufacturer.
331		-	10.33 (h) A manufacturer is subject to reasonable inspection by the commissioner office.
332		-	10Article 1 Sec. 13.
333		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 11.1 (i) For purposes of sections 152.22 to 152.37, a medical cannabis manufacturer is not
334		-	11.2subject to the Board of Pharmacy licensure or regulatory requirements under chapter 151.
335		-	11.3 (j) A medical cannabis manufacturer may not employ any person who is under 21 years
336		-	11.4of age or who has been convicted of a disqualifying felony offense. An employee of a
337		-	11.5medical cannabis manufacturer must submit a completed criminal history records check
338		-	11.6consent form, a full set of classifiable fingerprints, and the required fees for submission to
339		-	11.7the Bureau of Criminal Apprehension before an employee may begin working with the
340		-	11.8manufacturer. The bureau must conduct a Minnesota criminal history records check and
341		-	11.9the superintendent is authorized to exchange the fingerprints with the Federal Bureau of
342		-	11.10Investigation to obtain the applicant's national criminal history record information. The
343		-	11.11bureau shall return the results of the Minnesota and federal criminal history records checks
344		-	11.12to the commissioner office.
345		-	11.13 (k) A manufacturer may not operate in any location, whether for distribution or
346		-	11.14cultivation, harvesting, manufacturing, packaging, or processing, within 1,000 feet of a
347		-	11.15public or private school existing before the date of the manufacturer's registration with the
348		-	11.16commissioner office.
349		-	11.17 (l) A manufacturer shall comply with reasonable restrictions set by the commissioner
350		-	11.18office relating to signage, marketing, display, and advertising of medical cannabis.
351		-	11.19 (m) Before a manufacturer acquires hemp from a hemp grower or hemp products from
352		-	11.20a hemp processor, the manufacturer must verify that the hemp grower or hemp processor
353		-	11.21has a valid license issued by the commissioner of agriculture under chapter 18K.
354		-	11.22 (n) Until a state-centralized, seed-to-sale system is implemented that can track a specific
355		-	11.23medical cannabis plant from cultivation through testing and point of sale, the commissioner
356		-	11.24office shall conduct at least one unannounced inspection per year of each manufacturer that
357		-	11.25includes inspection of:
358		-	11.26 (1) business operations;
359		-	11.27 (2) physical locations of the manufacturer's manufacturing facility and distribution
360		-	11.28facilities;
361		-	11.29 (3) financial information and inventory documentation, including laboratory testing
362		-	11.30results; and
363		-	11.31 (4) physical and electronic security alarm systems.
364		-	11Article 1 Sec. 13.
365		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 12.1 Sec. 14. Minnesota Statutes 2024, section 152.29, subdivision 2, is amended to read:
366		-	12.2 Subd. 2.Manufacturer; production.(a) A manufacturer of medical cannabis shall
367		-	12.3provide a reliable and ongoing supply of all medical cannabis needed for the registry program
368		-	12.4through cultivation by the manufacturer and through the purchase of hemp from hemp
369		-	12.5growers.
370		-	12.6 (b) All cultivation, harvesting, manufacturing, packaging, and processing of medical
371		-	12.7cannabis must take place in an enclosed, locked facility at a physical address provided to
372		-	12.8the commissioner office during the registration process.
373		-	12.9 (c) A manufacturer must process and prepare any medical cannabis plant material or
374		-	12.10hemp plant material into a form allowable under section 152.22, subdivision 6, prior to
375		-	12.11distribution of any medical cannabis.
376		-	12.12Sec. 15. Minnesota Statutes 2024, section 152.29, subdivision 3a, is amended to read:
377		-	12.13 Subd. 3a.Transportation of medical cannabis; transport staffing.(a) A medical
378		-	12.14cannabis manufacturer may staff a transport motor vehicle with only one employee if the
379		-	12.15medical cannabis manufacturer is transporting medical cannabis to either a certified
380		-	12.16laboratory for the purpose of testing or a facility for the purpose of disposal. If the medical
381		-	12.17cannabis manufacturer is transporting medical cannabis for any other purpose or destination,
382		-	12.18the transport motor vehicle must be staffed with a minimum of two employees as required
383		-	12.19by rules adopted by the commissioner office.
384		-	12.20 (b) Notwithstanding paragraph (a), a medical cannabis manufacturer that is only
385		-	12.21transporting hemp for any purpose may staff the transport motor vehicle with only one
386		-	12.22employee.
387		-	12.23 (c) A medical cannabis manufacturer may contract with a third party for armored car
388		-	12.24services for deliveries of medical cannabis from its production facility to distribution
389		-	12.25facilities. A medical cannabis manufacturer that contracts for armored car services remains
390		-	12.26responsible for the transportation manifest and inventory tracking requirements in rules
391		-	12.27adopted by the commissioner office.
392		-	12.28 (d) Department of Health Office staff may transport medical cannabis for the purposes
393		-	12.29of delivering medical cannabis and other samples to a laboratory for testing under rules
394		-	12.30adopted by the commissioner office and in cases of special investigations when the
395		-	12.31commissioner office has determined there is a potential threat to public health. The transport
396		-	12.32motor vehicle must be staffed with a minimum of two Department of Health office
397		-	12Article 1 Sec. 15.
398		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 13.1employees. The employees must carry with them their Department of Health office
399		-	13.2identification card and a transport manifest.
400		-	13.3 Sec. 16. Minnesota Statutes 2024, section 152.29, subdivision 4, is amended to read:
401		-	13.4 Subd. 4.Report.(a) Each manufacturer shall report to the commissioner office on a
402		-	13.5monthly basis the following information on each individual patient for the month prior to
403		-	13.6the report:
404		-	13.7 (1) the amount and dosages of medical cannabis distributed;
405		-	13.8 (2) the chemical composition of the medical cannabis; and
406		-	13.9 (3) the tracking number assigned to any medical cannabis distributed.
407		-	13.10 (b) For transactions involving Tribal medical cannabis program patients, each
408		-	13.11manufacturer shall report to the commissioner office on a weekly basis the following
409		-	13.12information on each individual Tribal medical cannabis program patient for the week prior
410		-	13.13to the report:
411		-	13.14 (1) the name of the Tribal medical cannabis program in which the Tribal medical cannabis
412		-	13.15program patient is enrolled;
413		-	13.16 (2) the amount and dosages of medical cannabis distributed;
414		-	13.17 (3) the chemical composition of the medical cannabis distributed; and
415		-	13.18 (4) the tracking number assigned to the medical cannabis distributed.
416		-	13.19Sec. 17. Minnesota Statutes 2024, section 152.31, is amended to read:
417		-	13.20 152.31 DATA PRACTICES.
418		-	13.21 (a) Government data in patient files maintained by the commissioner office and the
419		-	13.22health care practitioner, and data submitted to or by a medical cannabis manufacturer, are
420		-	13.23private data on individuals, as defined in section 13.02, subdivision 12, or nonpublic data,
421		-	13.24as defined in section 13.02, subdivision 9, but may be used for purposes of complying with
422		-	13.25chapter 13 and complying with a request from the legislative auditor or the state auditor in
423		-	13.26the performance of official duties. The provisions of section 13.05, subdivision 11, apply
424		-	13.27to a registration agreement entered between the commissioner office and a medical cannabis
425		-	13.28manufacturer under section 152.25.
426		-	13Article 1 Sec. 17.
427		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 14.1 (b) Not public data maintained by the commissioner office may not be used for any
428		-	14.2purpose not provided for in sections 152.22 to 152.37, and may not be combined or linked
429		-	14.3in any manner with any other list, dataset, or database.
430		-	14.4 (c) The commissioner office may execute data sharing arrangements with the
431		-	14.5commissioner of agriculture to verify licensing, inspection, and compliance information
432		-	14.6related to hemp growers and hemp processors under chapter 18K.
433		-	14.7 Sec. 18. Minnesota Statutes 2024, section 152.32, subdivision 2, is amended to read:
434		-	14.8 Subd. 2.Criminal and civil protections.(a) Subject to section 152.23, the following
435		-	14.9are not violations under this chapter:
436		-	14.10 (1) use or possession of medical cannabis or medical cannabis products by a patient
437		-	14.11enrolled in the registry program; possession by a registered designated caregiver or the
438		-	14.12parent, legal guardian, or spouse of a patient if the parent, legal guardian, or spouse is listed
439		-	14.13on the registry verification; or use or possession of medical cannabis or medical cannabis
440		-	14.14products by a Tribal medical cannabis program patient;
441		-	14.15 (2) possession, dosage determination, or sale of medical cannabis or medical cannabis
442		-	14.16products by a medical cannabis manufacturer, employees of a manufacturer, a Tribal medical
443		-	14.17cannabis program manufacturer, employees of a Tribal medical cannabis program
444		-	14.18manufacturer, a laboratory conducting testing on medical cannabis, or employees of the
445		-	14.19laboratory; and
446		-	14.20 (3) possession of medical cannabis or medical cannabis products by any person while
447		-	14.21carrying out the duties required under sections 152.22 to 152.37.
448		-	14.22 (b) Medical cannabis obtained and distributed pursuant to sections 152.22 to 152.37 and
449		-	14.23associated property is not subject to forfeiture under sections 609.531 to 609.5316.
450		-	14.24 (c) The commissioner office, members of a Tribal medical cannabis board, the
451		-	14.25commissioner's office's or Tribal medical cannabis board's staff, the commissioner's office's
452		-	14.26or Tribal medical cannabis board's agents or contractors, and any health care practitioner
453		-	14.27are not subject to any civil or disciplinary penalties by the Board of Medical Practice, the
454		-	14.28Board of Nursing, or by any business, occupational, or professional licensing board or entity,
455		-	14.29solely for participation in the registry program under sections 152.22 to 152.37 or in a Tribal
456		-	14.30medical cannabis program. A pharmacist licensed under chapter 151 is not subject to any
457		-	14.31civil or disciplinary penalties by the Board of Pharmacy when acting in accordance with
458		-	14.32the provisions of sections 152.22 to 152.37. Nothing in this section affects a professional
459		-	14.33licensing board from taking action in response to violations of any other section of law.
460		-	14Article 1 Sec. 18.
461		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 15.1 (d) Notwithstanding any law to the contrary, the commissioner office, the governor of
462		-	15.2Minnesota, or an employee of any state agency may not be held civilly or criminally liable
463		-	15.3for any injury, loss of property, personal injury, or death caused by any act or omission
464		-	15.4while acting within the scope of office or employment under sections 152.22 to 152.37.
465		-	15.5 (e) Federal, state, and local law enforcement authorities are prohibited from accessing
466		-	15.6the patient registry under sections 152.22 to 152.37 except when acting pursuant to a valid
467		-	15.7search warrant.
468		-	15.8 (f) Notwithstanding any law to the contrary, neither the commissioner office nor a public
469		-	15.9employee may release data or information about an individual contained in any report,
470		-	15.10document, or registry created under sections 152.22 to 152.37 or any information obtained
471		-	15.11about a patient participating in the program, except as provided in sections 152.22 to 152.37.
472		-	15.12 (g) No information contained in a report, document, or registry or obtained from a patient
473		-	15.13under sections 152.22 to 152.37 or from a Tribal medical cannabis program patient may be
474		-	15.14admitted as evidence in a criminal proceeding unless independently obtained or in connection
475		-	15.15with a proceeding involving a violation of sections 152.22 to 152.37.
476		-	15.16 (h) Notwithstanding section 13.09, any person who violates paragraph (e) or (f) is guilty
477		-	15.17of a gross misdemeanor.
478		-	15.18 (i) An attorney may not be subject to disciplinary action by the Minnesota Supreme
479		-	15.19Court, a Tribal court, or the professional responsibility board for providing legal assistance
480		-	15.20to prospective or registered manufacturers or others related to activity that is no longer
481		-	15.21subject to criminal penalties under state law pursuant to sections 152.22 to 152.37, or for
482		-	15.22providing legal assistance to a Tribal medical cannabis program or a Tribal medical cannabis
483		-	15.23program manufacturer.
484		-	15.24 (j) The following do not constitute probable cause or reasonable suspicion, and shall not
485		-	15.25be used to support a search of the person or property of the person possessing or applying
486		-	15.26for the registry verification or equivalent, or otherwise subject the person or property of the
487		-	15.27person to inspection by any governmental agency:
488		-	15.28 (1) possession of a registry verification or application for enrollment in the registry
489		-	15.29program by a person entitled to possess a registry verification or apply for enrollment in
490		-	15.30the registry program; or
491		-	15.31 (2) possession of a verification or equivalent issued by a Tribal medical cannabis program
492		-	15.32or application for enrollment in a Tribal medical cannabis program by a person entitled to
493		-	15.33possess such a verification or application.
494		-	15Article 1 Sec. 18.
495		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 16.1 Sec. 19. Minnesota Statutes 2024, section 152.33, subdivision 1a, is amended to read:
496		-	16.2 Subd. 1a.Intentional diversion outside the state; penalties.(a) In addition to any other
497		-	16.3applicable penalty in law, the commissioner office may levy a fine of $250,000 against a
498		-	16.4manufacturer and may immediately initiate proceedings to revoke the manufacturer's
499		-	16.5registration, using the procedure in section 152.25, if:
500		-	16.6 (1) an officer, director, or controlling person of the manufacturer pleads or is found
501		-	16.7guilty under subdivision 1 of intentionally transferring medical cannabis, while the person
502		-	16.8was an officer, director, or controlling person of the manufacturer, to a person other than
503		-	16.9allowed by law; and
504		-	16.10 (2) in intentionally transferring medical cannabis to a person other than allowed by law,
505		-	16.11the officer, director, or controlling person transported or directed the transport of medical
506		-	16.12cannabis outside of Minnesota.
507		-	16.13 (b) All fines collected under this subdivision shall be deposited in the state government
508		-	16.14special revenue fund.
509		-	16.15Sec. 20. Minnesota Statutes 2024, section 152.33, subdivision 4, is amended to read:
510		-	16.16 Subd. 4.Submission of false records; criminal penalty.A person who knowingly
511		-	16.17submits false records or documentation required by the commissioner office to register as
512		-	16.18a manufacturer of medical cannabis under sections 152.22 to 152.37 is guilty of a felony
513		-	16.19and may be sentenced to imprisonment for not more than two years or by payment of a fine
514		-	16.20of not more than $3,000, or both.
515		-	16.21Sec. 21. Minnesota Statutes 2024, section 152.35, is amended to read:
516		-	16.22 152.35 FEES; DEPOSIT OF REVENUE.
517		-	16.23 (a) The commissioner office shall collect an application fee of $20,000 from each entity
518		-	16.24submitting an application for registration as a medical cannabis manufacturer. Revenue
519		-	16.25from the fee shall be deposited in the state treasury and credited to the state government
520		-	16.26special revenue fund.
521		-	16.27 (b) The commissioner office shall establish and collect an annual fee from a medical
522		-	16.28cannabis manufacturer equal to the cost of regulating and inspecting the manufacturer in
523		-	16.29that year. Revenue from the fee amount shall be deposited in the state treasury and credited
524		-	16.30to the state government special revenue fund.
525		-	16Article 1 Sec. 21.
526		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 17.1 (c) A medical cannabis manufacturer may charge patients enrolled in the registry program
527		-	17.2a reasonable fee for costs associated with the operations of the manufacturer. The
528		-	17.3manufacturer may establish a sliding scale of patient fees based upon a patient's household
529		-	17.4income and may accept private donations to reduce patient fees.
530		-	17.5 Sec. 22. Minnesota Statutes 2024, section 152.37, is amended to read:
531		-	17.6 152.37 FINANCIAL EXAMINATIONS; PRICING REVIEWS.
532		-	17.7 Subdivision 1.Financial records.A medical cannabis manufacturer shall maintain
533		-	17.8detailed financial records in a manner and format approved by the commissioner office,
534		-	17.9and shall keep all records updated and accessible to the commissioner office when requested.
535		-	17.10 Subd. 2.Certified annual audit.A medical cannabis manufacturer shall submit the
536		-	17.11results of an annual certified financial audit to the commissioner office no later than May
537		-	17.121 of each year for the calendar year beginning January 2015. The annual audit shall be
538		-	17.13conducted by an independent certified public accountant and the costs of the audit are the
539		-	17.14responsibility of the medical cannabis manufacturer. Results of the audit shall be provided
540		-	17.15to the medical cannabis manufacturer and the commissioner office. The commissioner office
541		-	17.16may also require another audit of the medical cannabis manufacturer by a certified public
542		-	17.17accountant chosen by the commissioner office with the costs of the audit paid by the medical
543		-	17.18cannabis manufacturer.
544		-	17.19 Subd. 3.Power to examine.(a) The commissioner office or designee may examine the
545		-	17.20business affairs and conditions of any medical cannabis manufacturer, including but not
546		-	17.21limited to a review of the financing, budgets, revenues, sales, and pricing.
547		-	17.22 (b) An examination may cover the medical cannabis manufacturer's business affairs,
548		-	17.23practices, and conditions including but not limited to a review of the financing, budgets,
549		-	17.24revenues, sales, and pricing. The commissioner office shall determine the nature and scope
550		-	17.25of each examination and in doing so shall take into account all available relevant factors
551		-	17.26concerning the financial and business affairs, practices, and conditions of the examinee.
552		-	17.27The costs incurred by the department in conducting an examination shall be paid for by the
553		-	17.28medical cannabis manufacturer.
554		-	17.29 (c) When making an examination under this section, the commissioner office may retain
555		-	17.30attorneys, appraisers, independent economists, independent certified public accountants, or
556		-	17.31other professionals and specialists as designees. A certified public accountant retained by
557		-	17.32the commissioner office may not be the same certified public accountant providing the
558		-	17.33certified annual audit in subdivision 2.
559		-	17Article 1 Sec. 22.
560		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 18.1 (d) The commissioner office shall make a report of an examination conducted under this
561		-	18.2section and provide a copy to the medical cannabis manufacturer. The commissioner office
562		-	18.3shall then post a copy of the report on the department's website. All working papers, recorded
563		-	18.4information, documents, and copies produced by, obtained by, or disclosed to the
564		-	18.5commissioner office or any other person in the course of an examination, other than the
565		-	18.6information contained in any commissioner office official report, made under this section
566		-	18.7are private data on individuals or nonpublic data, as defined in section 13.02.
567		-	18.8 Sec. 23. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to
568		-	18.9read:
569		-	18.10 Subd. 54a.Medical cannabis paraphernalia."Medical cannabis paraphernalia" means
570		-	18.11a delivery device, related supply, or educational material used by a patient enrolled in the
571		-	18.12registry program to administer medical cannabis and medical cannabinoid products.
572		-	18.13Sec. 24. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to
573		-	18.14read:
574		-	18.15 Subd. 69c.Tribal medical cannabis board."Tribal medical cannabis board" means an
575		-	18.16agency established by a federally recognized Tribal government and authorized by the
576		-	18.17Tribe's governing body to provide regulatory oversight and monitor compliance with a
577		-	18.18Tribal medical cannabis program and applicable regulations.
578		-	18.19Sec. 25. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to
579		-	18.20read:
580		-	18.21 Subd. 69d.Tribal medical cannabis program."Tribal medical cannabis program"
581		-	18.22means a program established by a federally recognized Tribal government within the
582		-	18.23boundaries of Minnesota that involves the commercial production, processing, sale or
583		-	18.24distribution, and possession of medical cannabis and medical cannabis products.
584		-	18.25Sec. 26. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to
585		-	18.26read:
586		-	18.27 Subd. 69e.Tribal medical cannabis program patient."Tribal medical cannabis program
587		-	18.28patient" means a person who possesses a valid registration verification card or equivalent
588		-	18.29document that is issued under the laws or regulations of a Tribal Nation within the boundaries
589		-	18.30of Minnesota. A valid registration verification card must verify that the card holder is
590		-	18.31enrolled in or authorized to participate in a Tribal medical cannabis program.
591		-	18Article 1 Sec. 26.
592		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 19.1 Sec. 27. Minnesota Statutes 2024, section 342.01, subdivision 71, is amended to read:
593		-	19.2 Subd. 71.Visiting patient."Visiting patient" means an individual who is not a Minnesota
594		-	19.3resident and who possesses a valid registration verification card or its equivalent that is
595		-	19.4issued under the laws or regulations of another state, district, commonwealth, or territory
596		-	19.5of the United States verifying that the individual is enrolled in or authorized to participate
597		-	19.6in that jurisdiction's medical cannabis or medical marijuana program or in a Tribal medical
598		-	19.7cannabis program.
599		-	19.8 Sec. 28. Minnesota Statutes 2024, section 342.02, subdivision 3, is amended to read:
600		-	19.9 Subd. 3.Medical cannabis program.(a) The powers and duties of the Department of
601		-	19.10Health with respect to the medical cannabis program under Minnesota Statutes 2022, sections
602		-	19.11152.22 to 152.37, are transferred to the Office of Cannabis Management under section
603		-	19.1215.039.
604		-	19.13 (b) The following protections shall apply to employees who are transferred from the
605		-	19.14Department of Health to the Office of Cannabis Management:
606		-	19.15 (1) the employment status and job classification of a transferred employee shall not be
607		-	19.16altered as a result of the transfer;
608		-	19.17 (2) transferred employees who were represented by an exclusive representative prior to
609		-	19.18the transfer shall continue to be represented by the same exclusive representative after the
610		-	19.19transfer;
611		-	19.20 (3) the applicable collective bargaining agreements with exclusive representatives shall
612		-	19.21continue in full force and effect for such transferred employees after the transfer;
613		-	19.22 (4) the state must meet and negotiate with the exclusive representatives of the transferred
614		-	19.23employees about any proposed changes affecting or relating to the transferred employees'
615		-	19.24terms and conditions of employment to the extent such changes are not addressed in the
616		-	19.25applicable collective bargaining agreement; and
617		-	19.26 (5) for an employee in a temporary unclassified position transferred to the Office of
618		-	19.27Cannabis Management, the total length of time that the employee has served in the
619		-	19.28appointment shall include all time served in the appointment and the transferring agency
620		-	19.29and the time served in the appointment at the Office of Cannabis Management. An employee
621		-	19.30in a temporary unclassified position who was hired by a transferring agency through an
622		-	19.31open competitive selection process in accordance with a policy enacted by Minnesota
623		-	19.32Management and Budget shall be considered to have been hired through such process after
624		-	19.33the transfer.
625		-	19Article 1 Sec. 28.
626		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 20.1 (c) This subdivision is effective July 1, 2024.
627		-	20.2 Sec. 29. Minnesota Statutes 2024, section 342.09, subdivision 2, is amended to read:
628		-	20.3 Subd. 2.Home cultivation of cannabis for personal adult use.(a) Up to eight cannabis
629		-	20.4plants, with no more than four being mature, flowering plants may be grown at a single
630		-	20.5residence, including the curtilage or yard, without a license to cultivate cannabis issued
631		-	20.6under this chapter provided that cultivation takes place at the primary residence of an
632		-	20.7individual 21 years of age or older and in an enclosed, locked space that is not open to public
633		-	20.8view.
634		-	20.9 (b) Pursuant to section 342.52, subdivision 9, paragraph (d), a registered designated
635		-	20.10caregiver may cultivate up to eight cannabis plants for not more than one patient household.
636		-	20.11In addition to eight cannabis plants for one patient household, a registered designated
637		-	20.12caregiver may cultivate up to eight cannabis plants for the caregiver's personal adult use of
638		-	20.13cannabis. Of the 16 or fewer total cannabis plants being grown in the registered caregiver's
639		-	20.14residence, no more than eight may be mature, flowering plants.
640		-	20.15Sec. 30. Minnesota Statutes 2024, section 342.51, subdivision 2, is amended to read:
641		-	20.16 Subd. 2.Distribution requirements.(a) Prior to distribution of medical cannabis flower
642		-	20.17or medical cannabinoid products to a person enrolled in the registry program, an employee
643		-	20.18with a valid medical cannabis consultant certificate issued by the office or a licensed
644		-	20.19pharmacist under chapter 151 of a cannabis business must:
645		-	20.20 (1) review and confirm the patient's enrollment in the registry program;
646		-	20.21 (2) verify that the person requesting the distribution of medical cannabis flower or
647		-	20.22medical cannabinoid products is the patient, the patient's registered designated caregiver,
648		-	20.23or the patient's parent, legal guardian, or spouse using the procedures established by the
649		-	20.24office;
650		-	20.25 (3) provide confirm that the patient had a consultation to the patient with (i) an employee
651		-	20.26with a valid medical cannabis consultant certificate issued by the office; or (ii) an employee
652		-	20.27who is a licensed pharmacist under chapter 151 to determine the proper medical cannabis
653		-	20.28flower or medical cannabinoid product, dosage, and paraphernalia for the patient if required
654		-	20.29under subdivision 3;
655		-	20.30 (4) apply a patient-specific label on the medical cannabis flower or medical cannabinoid
656		-	20.31product that includes recommended dosage requirements and other information as required
657		-	20.32by the office; and
658		-	20Article 1 Sec. 30.
659		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 21.1 (5) provide the patient with any other information required by the office.
660		-	21.2 (b) A cannabis business with a medical cannabis retail endorsement may not deliver
661		-	21.3medical cannabis flower or medical cannabinoid products to a person enrolled in the registry
662		-	21.4program unless the cannabis business with a medical cannabis retail endorsement also holds
663		-	21.5a cannabis delivery service license. The delivery of medical cannabis flower and medical
664		-	21.6cannabinoid products are subject to the provisions of section 342.42.
665		-	21.7 Sec. 31. Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to
666		-	21.8read:
667		-	21.9 Subd. 2a.Distribution to visiting patients.(a) A cannabis business with a medical
668		-	21.10cannabis retail endorsement may distribute medical cannabis flower or medical cannabinoid
669		-	21.11products to a visiting patient.
670		-	21.12 (b) Before receiving a distribution of medical cannabis, a visiting patient must provide
671		-	21.13to an employee of the cannabis business:
672		-	21.14 (1) a valid medical cannabis registration verification card or equivalent document issued
673		-	21.15under the laws and regulations of another state, district, commonwealth, Tribal Nation, or
674		-	21.16territory that indicates that the visiting patient is authorized to use medical cannabis in the
675		-	21.17issuing jurisdiction; and
676		-	21.18 (2) a valid photographic identification card issued by the visiting patient's medical
677		-	21.19cannabis program, a valid driver's license, or a valid state identification card.
678		-	21.20 (c) Prior to the distribution of medical cannabis flower or medical cannabinoid products
679		-	21.21to a visiting patient, an employee of a cannabis business must:
680		-	21.22 (1) ensure that a patient-specific label has been applied to all medical cannabis flower
681		-	21.23and medical cannabinoid products. The label must include the recommended dosage
682		-	21.24requirements and other information required by the office; and
683		-	21.25 (2) provide the patient with any other information required by the office.
684		-	21.26 (d) For each transaction that involves a visiting patient, a cannabis business with a
685		-	21.27medical cannabis retail endorsement must report to the office on a weekly basis:
686		-	21.28 (1) the name of the visiting patient;
687		-	21.29 (2) the name of the medical cannabis program in which the visiting patient is enrolled;
688		-	21.30 (3) the amount and dosages of medical cannabis distributed;
689		-	21.31 (4) the chemical composition of the medical cannabis distributed; and
690		-	21Article 1 Sec. 31.
691		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 22.1 (5) the tracking number assigned to the medical cannabis that was distributed to the
692		-	22.2visiting patient.
693		-	22.3 (e) A cannabis business with a medical cannabis retail endorsement may distribute
694		-	22.4medical cannabis flower and medical cannabinoid products to a visiting patient in a motor
695		-	22.5vehicle if:
696		-	22.6 (1) an employee of the cannabis business receives payment and distributes medical
697		-	22.7cannabis flower and medical cannabinoid products in a designated zone that is as close as
698		-	22.8feasible to the front door of the facility where the cannabis business is located;
699		-	22.9 (2) the cannabis business with a medical cannabis retail endorsement ensures that the
700		-	22.10receipt of payment and distribution of medical cannabis flower and medical cannabinoid
701		-	22.11products are visually recorded by a closed-circuit television surveillance camera and provides
702		-	22.12any other necessary security safeguards required by the office;
703		-	22.13 (3) the cannabis business with a medical cannabis retail endorsement does not store
704		-	22.14medical cannabis flower or medical cannabinoid products outside a restricted access area;
705		-	22.15 (4) an employee of the cannabis business transports medical cannabis flower and medical
706		-	22.16cannabinoid products from a restricted access area to the designated zone for distribution
707		-	22.17to patients only after confirming that the visiting patient has arrived in the designated zone;
708		-	22.18 (5) the payment for and distribution of medical cannabis flower and medical cannabinoid
709		-	22.19products to a patient only occurs after meeting the requirements in paragraph (b);
710		-	22.20 (6) immediately following the distribution of medical cannabis flower or medical
711		-	22.21cannabinoid products to a patient, an employee of the cannabis business records the
712		-	22.22transaction in the statewide monitoring system; and
713		-	22.23 (7) immediately following the distribution of medical cannabis flower and medical
714		-	22.24cannabinoid products, an employee of the cannabis business transports all payments received
715		-	22.25into the facility where the cannabis business is located.
716		-	22.26Sec. 32. Minnesota Statutes 2024, section 342.515, subdivision 1, is amended to read:
717		-	22.27 Subdivision 1.Authorized actions.(a) A person, cooperative, or business holding a
718		-	22.28medical cannabis combination business license is prohibited from owning or operating any
719		-	22.29other cannabis business or hemp business or holding an active registration agreement under
720		-	22.30section 152.25, subdivision 1.
721		-	22.31 (b) A person or business may hold only one medical cannabis combination business
722		-	22.32license.
723		-	22Article 1 Sec. 32.
724		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 23.1 (c) A medical cannabis combination business license entitles the license holder to perform
725		-	23.2any or all of the following within the limits established by this section:
726		-	23.3 (1) grow cannabis plants from seed or immature plant to mature plant and harvest
727		-	23.4adult-use cannabis flower and medical cannabis flower from a mature plant;
728		-	23.5 (2) make cannabis concentrate;
729		-	23.6 (3) make hemp concentrate, including hemp concentrate with a delta-9
730		-	23.7tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
731		-	23.8 (4) manufacture artificially derived cannabinoids;
732		-	23.9 (5) manufacture medical cannabinoid products;
733		-	23.10 (6) manufacture adult-use cannabis products, lower-potency hemp edibles, and
734		-	23.11hemp-derived consumer products for public consumption;
735		-	23.12 (7) purchase immature cannabis plants and seedlings and cannabis flower from a cannabis
736		-	23.13microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a cannabis wholesaler,
737		-	23.14or another medical cannabis combination business;
738		-	23.15 (8) purchase hemp plant parts and propagules from an industrial hemp grower licensed
739		-	23.16under chapter 18K;
740		-	23.17 (9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids
741		-	23.18from a cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a
742		-	23.19cannabis wholesaler, or another medical cannabis combination business;
743		-	23.20 (10) purchase hemp concentrate from an industrial hemp processor licensed under chapter
744		-	23.2118K;
745		-	23.22 (11) package and label medical cannabis flower and medical cannabinoid products for
746		-	23.23sale to cannabis businesses with a medical cannabis processor endorsement, cannabis
747		-	23.24businesses with a medical cannabis retail endorsement, other medical cannabis combination
748		-	23.25businesses, and persons in the registry program;
749		-	23.26 (12) package and label adult-use cannabis flower, adult-use cannabis products,
750		-	23.27lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
751		-	23.28 (13) sell medical cannabis flower and medical cannabinoid products to other cannabis
752		-	23.29businesses with a medical endorsement, other medical cannabis combination businesses,
753		-	23.30and patients enrolled in the registry program, registered designated caregivers, and parents,
754		-	23.31legal guardians, and spouses of an enrolled patient;
755		-	23Article 1 Sec. 32.
756		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 24.1 (14) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use
757		-	24.2cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and
758		-	24.3other products authorized by law to other cannabis businesses and to customers; and
759		-	24.4 (15) perform other actions approved by the office.
760		-	24.5 (d) A medical cannabis combination business is not required to obtain a medical cannabis
761		-	24.6endorsement to perform any actions authorized under this section.
762		-	24.7 Sec. 33. Minnesota Statutes 2024, section 342.515, subdivision 5, is amended to read:
763		-	24.8 Subd. 5.Failure to participate; suspension or revocation of license.(a) A medical
764		-	24.9cannabis combination business must provide a reliable, ongoing supply of medical
765		-	24.10cannabinoid products to the registry program. Providing a reliable, ongoing supply includes
766		-	24.11but is not limited to:
767		-	24.12 (1) making the three most commonly purchased medical cannabinoid products available
768		-	24.13for wholesale; and
769		-	24.14 (2) if there is a shortage of medical cannabis flower or medical cannabinoid products,
770		-	24.15maintaining a stock of the three most commonly purchased medical cannabinoid products
771		-	24.16at the retail location of the medical cannabis combination business.
772		-	24.17 (b) The requirements under paragraph (a), clauses (1) and (2), do not apply to medical
773		-	24.18cannabis flower.
774		-	24.19 (c) A medical cannabis combination business must prioritize serving medical patients
775		-	24.20and caregivers before serving adult-use consumers.
776		-	24.21 (d) The office may suspend or revoke A medical cannabis combination business license
777		-	24.22if the office determines that the business is no longer actively participating in the medical
778		-	24.23cannabis market. The office may, by rule, establish minimum requirements related to
779		-	24.24cannabis cultivation, manufacturing of medical cannabinoid products, retail sales of medical
780		-	24.25cannabis flower and medical cannabinoid products, and other relevant criteria to demonstrate
781		-	24.26active participation in the medical cannabis market.
782		-	24.27Sec. 34. Minnesota Statutes 2024, section 342.52, is amended by adding a subdivision to
783		-	24.28read:
784		-	24.29 Subd. 7a.Allowable delivery methods.A patient in the registry program may receive
785		-	24.30medical cannabis flower and medical cannabinoid products. The office may approve
786		-	24Article 1 Sec. 34.
787		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 25.1additional delivery methods to expand the types of products that qualify as medical
788		-	25.2cannabinoid products.
789		-	25.3 Sec. 35. Minnesota Statutes 2024, section 342.52, subdivision 9, is amended to read:
790		-	25.4 Subd. 9.Registered designated caregiver.(a) The office must register a designated
791		-	25.5caregiver for a patient if the patient requires assistance in administering medical cannabis
792		-	25.6flower or medical cannabinoid products; obtaining medical cannabis flower, medical
793		-	25.7cannabinoid products, or medical cannabis paraphernalia from a cannabis business with a
794		-	25.8medical cannabis retail endorsement; or cultivating cannabis plants as permitted by section
795		-	25.9342.09, subdivision 2.
796		-	25.10 (b) In order to serve as a designated caregiver, a person must:
797		-	25.11 (1) be at least 18 years of age;
798		-	25.12 (2) agree to only possess the patient's medical cannabis flower and medical cannabinoid
799		-	25.13products for purposes of assisting the patient; and
800		-	25.14 (3) agree that if the application is approved, the person will not serve as a registered
801		-	25.15designated caregiver for more than six registered patients at one time. Patients who reside
802		-	25.16in the same residence count as one patient.
803		-	25.17 (c) Nothing in this section shall be construed to prevent a registered designated caregiver
804		-	25.18from being enrolled in the registry program as a patient and possessing and administering
805		-	25.19medical cannabis flower or medical cannabinoid products as a patient.
806		-	25.20 (d) Notwithstanding any law to the contrary, a registered designated caregiver approved
807		-	25.21to assist a patient enrolled in the registry program with obtaining medical cannabis flower
808		-	25.22may cultivate cannabis plants on behalf of one patient. A registered designated caregiver
809		-	25.23may grow up to eight cannabis plants for the patient household that the registered designated
810		-	25.24caregiver is approved to assist with obtaining medical cannabis flower. If a patient enrolled
811		-	25.25in the registry program directs the patient's registered designated caregiver to cultivate
812		-	25.26cannabis plants on behalf of the patient, the patient must assign the patient's right to cultivate
813		-	25.27cannabis plants to the registered designated caregiver and the notify the office. A patient
814		-	25.28who assigns the patient's right to cultivate cannabis plants to a registered caregiver is
815		-	25.29prohibited from cultivating cannabis plants for personal use. Nothing in this paragraph limits
816		-	25.30the right of a registered designated caregiver cultivating cannabis plants on behalf of a
817		-	25.31patient enrolled in the registry program to also cultivate cannabis plants for personal use
818		-	25.32pursuant to section 342.09, subdivision 2.
819		-	25Article 1 Sec. 35.
820		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 26.1 Sec. 36. Minnesota Statutes 2024, section 342.57, is amended to read:
821		-	26.2 342.57 PROTECTIONS FOR REGISTRY PROGRAM PARTICIPANTS.
822		-	26.3 Subdivision 1.Presumption.(a) There is a presumption that a patient or other person
823		-	26.4an individual enrolled in the registry program or a Tribal medical cannabis program patient
824		-	26.5is engaged in the authorized use or possession of medical cannabis flower and medical
825		-	26.6cannabinoid products.
826		-	26.7 (b) This presumption may be rebutted by evidence that:
827		-	26.8 (1) the use or possession of medical cannabis flower or medical cannabinoid products
828		-	26.9by a patient or other person enrolled in the registry program was not for the purpose of
829		-	26.10assisting with, treating, or alleviating the patient's qualifying medical condition or symptoms
830		-	26.11associated with the patient's qualifying medical condition.; or
831		-	26.12 (2) a Tribal medical cannabis program patient's use of medical cannabis was not for a
832		-	26.13purpose authorized by the Tribal medical cannabis program.
833		-	26.14 Subd. 2.Criminal and civil protections.(a) Subject to section 342.56, the following
834		-	26.15are not violations of this chapter or chapter 152:
835		-	26.16 (1) use or possession of medical cannabis flower, medical cannabinoid products, or
836		-	26.17medical cannabis paraphernalia by a patient enrolled in the registry program or by, a visiting
837		-	26.18patient, or a Tribal medical cannabis program patient to whom medical cannabis flower or
838		-	26.19medical cannabinoid products are distributed under section 342.51, subdivision 5;
839		-	26.20 (2) possession of medical cannabis flower, medical cannabinoid products, or medical
840		-	26.21cannabis paraphernalia by a registered designated caregiver or a parent, legal guardian, or
841		-	26.22spouse of a patient enrolled in the registry program; or
842		-	26.23 (3) possession of medical cannabis flower, medical cannabinoid products, or medical
843		-	26.24cannabis paraphernalia by any person while carrying out duties required under sections
844		-	26.25342.51 to 342.60.
845		-	26.26 (b) The Office of Cannabis Management, members of the Cannabis Advisory Council,
846		-	26.27Office of Cannabis Management employees, agents or contractors of the Office of Cannabis
847		-	26.28Management, members of a Tribal medical cannabis board, a Tribal medical cannabis board's
848		-	26.29staff, a Tribal medical cannabis board's agents or contractors, and health care practitioners
849		-	26.30participating in the registry program are not subject to any civil penalties or disciplinary
850		-	26.31action by the Board of Medical Practice, the Board of Nursing, or any business, occupational,
851		-	26.32or professional licensing board or entity solely for participating in the registry program or
852		-	26.33a Tribal medical cannabis program either in a professional capacity or as a patient. A
853		-	26Article 1 Sec. 36.
854		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 27.1pharmacist licensed under chapter 151 is not subject to any civil penalties or disciplinary
855		-	27.2action by the Board of Pharmacy when acting in accordance with sections 342.51 to 342.60
856		-	27.3either in a professional capacity or as a patient. Nothing in this section prohibits a professional
857		-	27.4licensing board from taking action in response to a violation of law.
858		-	27.5 (c) Notwithstanding any law to the contrary, a Cannabis Advisory Council member, the
859		-	27.6governor, or an employee of a state agency must not be held civilly or criminally liable for
860		-	27.7any injury, loss of property, personal injury, or death caused by any act or omission while
861		-	27.8acting within the scope of office or employment under sections 342.51 to 342.60.
862		-	27.9 (d) Federal, state, and local law enforcement authorities are prohibited from accessing
863		-	27.10the registry except when acting pursuant to a valid search warrant. Notwithstanding section
864		-	27.1113.09, a violation of this paragraph is a gross misdemeanor.
865		-	27.12 (e) Notwithstanding any law to the contrary, the office and employees of the office must
866		-	27.13not release data or information about an individual contained in any report or document or
867		-	27.14in the registry and must not release data or information obtained about a patient enrolled in
868		-	27.15the registry program, except as provided in sections 342.51 to 342.60. Notwithstanding
869		-	27.16section 13.09, a violation of this paragraph is a gross misdemeanor.
870		-	27.17 (f) No information contained in a report or document, contained in the registry, or
871		-	27.18obtained from a patient under sections 342.51 to 342.60 or from a Tribal medical cannabis
872		-	27.19program patient may be admitted as evidence in a criminal proceeding, unless:
873		-	27.20 (1) the information is independently obtained; or
874		-	27.21 (2) admission of the information is sought in a criminal proceeding involving a criminal
875		-	27.22violation of sections 342.51 to 342.60.
876		-	27.23 (g) Possession of a registry verification or an application for enrollment in the registry
877		-	27.24program and possession of a verification or its equivalent issued by a Tribal medical cannabis
878		-	27.25program or application for enrollment in a Tribal medical cannabis program by a person
879		-	27.26entitled to possess the verification or application:
880		-	27.27 (1) does not constitute probable cause or reasonable suspicion;
881		-	27.28 (2) must not be used to support a search of the person or property of the person with a
882		-	27.29registry verification or application to enroll in the registry program; and
883		-	27.30 (3) must not subject the person or the property of the person to inspection by any
884		-	27.31government agency.
885		-	27Article 1 Sec. 36.
886		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 28.1 (h) A patient enrolled in the registry program or a Tribal medical cannabis program must
887		-	28.2not be subject to any penalty or disciplinary action by an occupational or a professional
888		-	28.3licensing board solely because:
889		-	28.4 (1) the patient is enrolled in the registry program; or
890		-	28.5 (2) the patient has a positive test for cannabis components or metabolites.
891		-	28.6 Subd. 3.School enrollment; rental property.(a) No school may refuse to enroll or
892		-	28.7otherwise penalize a patient or person enrolled in the registry program as a pupil solely
893		-	28.8because the patient or person is enrolled in the registry program or a Tribal medical cannabis
894		-	28.9program, unless failing to do so would violate federal law or regulations or cause the school
895		-	28.10to lose a monetary or licensing-related benefit under federal law or regulations.
896		-	28.11 (b) No landlord may refuse to lease to a patient or person enrolled in the registry program
897		-	28.12or otherwise penalize a patient or person enrolled in the registry program solely because
898		-	28.13the patient or person is enrolled in the registry program or a Tribal medical cannabis program,
899		-	28.14unless failing to do so would violate federal law or regulations or cause the landlord to lose
900		-	28.15a monetary or licensing-related benefit under federal law or regulations.
901		-	28.16 (c) A school must not refuse to enroll a patient as a pupil solely because cannabis is a
902		-	28.17controlled substance according to the Uniform Controlled Substances Act, United States
903		-	28.18Code, title 21, section 812.
904		-	28.19 (d) A school must not penalize a pupil who is a patient solely because cannabis is a
905		-	28.20controlled substance according to the Uniform Controlled Substances Act, United States
906		-	28.21Code, title 21, section 812.
907		-	28.22 (e) A landlord must not refuse to lease a property to a patient solely because cannabis
908		-	28.23is a controlled substance according to the Uniform Controlled Substances Act, United States
909		-	28.24Code, title 21, section 812.
910		-	28.25 (f) A landlord must not otherwise penalize a patient solely because cannabis is a controlled
911		-	28.26substance according to the Uniform Controlled Substances Act, United States Code, title
912		-	28.2721, section 812.
913		-	28.28 Subd. 4.Medical care.For purposes of medical care, including organ transplants, a
914		-	28.29patient's use of medical cannabis flower or medical cannabinoid products according to
915		-	28.30sections 342.51 to 342.60, or a Tribal medical cannabis program patient's use of medical
916		-	28.31cannabis as authorized by the Tribal medical cannabis program, is considered the equivalent
917		-	28.32of the authorized use of a medication used at the discretion of a health care practitioner and
918		-	28.33does not disqualify a patient from needed medical care.
919		-	28Article 1 Sec. 36.
920		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 29.1 Subd. 5.Employment.(a) Unless a failure to do so would violate federal or state law
921		-	29.2or regulations or cause an employer to lose a monetary or licensing-related benefit under
922		-	29.3federal law or regulations, an employer may not discriminate against a person in hiring,
923		-	29.4termination, or any term or condition of employment, or otherwise penalize a person, if the
924		-	29.5discrimination is based on:
925		-	29.6 (1) the person's status as a patient or person an individual enrolled in the registry program;
926		-	29.7or
927		-	29.8 (2) the person's status as a Tribal medical cannabis program patient; or
928		-	29.9 (2) (3) a patient's positive drug test for cannabis components or metabolites, unless the
929		-	29.10patient used, possessed, sold, transported, or was impaired by medical cannabis flower or
930		-	29.11a medical cannabinoid product on work premises, during working hours, or while operating
931		-	29.12an employer's machinery, vehicle, or equipment.
932		-	29.13 (b) An employee who is a patient in the registry program or a Tribal medical cannabis
933		-	29.14program and whose employer requires the employee to undergo drug testing according to
934		-	29.15section 181.953 may present the employee's registry verification or verification of enrollment
935		-	29.16in a Tribal medical cannabis program as part of the employee's explanation under section
936		-	29.17181.953, subdivision 6.
937		-	29.18 Subd. 5a.Notice.An employer, a school, or a landlord must provide written notice to
938		-	29.19a patient at least 14 days before the employer, school, or landlord takes an action against
939		-	29.20the patient that is prohibited under subdivision 3 or 5. The written notice must cite the
940		-	29.21specific federal law or regulation that the employer, school, or landlord believes would be
941		-	29.22violated if the employer, school, or landlord fails to take action. The notice must specify
942		-	29.23what monetary or licensing-related benefit under federal law or regulations that the employer,
943		-	29.24school, or landlord would lose if the employer, school, or landlord fails to take action.
944		-	29.25 Subd. 6.Custody; visitation; parenting time.A person must not be denied custody of
945		-	29.26a minor child or visitation rights or parenting time with a minor child based solely on the
946		-	29.27person's status as a patient or person an individual enrolled in the registry program or on
947		-	29.28the person's status as a Tribal medical cannabis program patient. There must be no
948		-	29.29presumption of neglect or child endangerment for conduct allowed under sections 342.51
949		-	29.30to 342.60 or under a Tribal medical cannabis program, unless the person's behavior creates
950		-	29.31an unreasonable danger to the safety of the minor as established by clear and convincing
951		-	29.32evidence.
952		-	29Article 1 Sec. 36.
953		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 30.1 Subd. 6a.Retaliation prohibited.A school, a landlord, a health care facility, or an
954		-	30.2employer must not retaliate against a patient for asserting the patient's rights or seeking
955		-	30.3remedies under this section or section 152.32.
956		-	30.4 Subd. 7.Action for damages; injunctive relief.In addition to any other remedy provided
957		-	30.5by law, a patient or person an individual enrolled in the registry program or a Tribal medical
958		-	30.6cannabis program may bring an action for damages against any person who violates
959		-	30.7subdivision 3, 4, or 5. A person who violates subdivision 3, 4, or 5 is liable to a patient or
960		-	30.8person an individual enrolled in the registry program or a Tribal medical cannabis program
961		-	30.9injured by the violation for the greater of the person's actual damages or a civil penalty of
962		-	30.10$100 $1,000 and reasonable attorney fees. A patient may bring an action for injunctive relief
963		-	30.11to prevent or end a violation of subdivisions 3 to 6a.
964		-	30.12 Subd. 8.Sanctions restricted for those on parole, supervised release, or conditional
965		-	30.13release.(a) This subdivision applies to an individual placed on parole, supervised release,
966		-	30.14or conditional release.
967		-	30.15 (b) The commissioner of corrections may not:
968		-	30.16 (1) prohibit an individual from participating in the registry program or a Tribal medical
969		-	30.17cannabis program as a condition of release; or
970		-	30.18 (2) revoke an individual's parole, supervised release, or conditional release or otherwise
971		-	30.19sanction an individual solely:
972		-	30.20 (i) for participating in the registry program or a Tribal medical cannabis program; or
973		-	30.21 (ii) for a positive drug test for cannabis components or metabolites.
974		-	30.22Sec. 37. Minnesota Statutes 2024, section 342.59, subdivision 2, is amended to read:
975		-	30.23 Subd. 2.Allowable use; prohibited use.Data specified in subdivision 1 may be used
976		-	30.24to comply with chapter 13, to comply with a request from the legislative auditor or the state
977		-	30.25auditor in the performance of official duties, and for purposes specified in sections 342.47
978		-	30.26342.51 to 342.60. Data specified in subdivision 1 and maintained by the Office of Cannabis
979		-	30.27Management or Division of Medical Cannabis must not be used for any purpose not specified
980		-	30.28in sections 342.47 342.51 to 342.60 and must not be combined or linked in any manner
981		-	30.29with any other list, dataset, or database. Data specified in subdivision 1 must not be shared
982		-	30.30with any federal agency, federal department, or federal entity unless specifically ordered
983		-	30.31to do so by a state or federal court.
984		-	30Article 1 Sec. 37.
985		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 31.1 Sec. 38. REPEALER.
986		-	31.2 Minnesota Statutes 2024, sections 152.22, subdivision 2; and 342.151, subdivision 1,
987		-	31.3are repealed.
988		-	31.4 ARTICLE 2
989		-	31.5 CANNABIS BUSINESS LICENSING AND OPERATIONS
990		-	31.6 Section 1. Minnesota Statutes 2024, section 342.12, is amended to read:
991		-	31.7 342.12 LICENSES; TRANSFERS; ADJUSTMENTS.
992		-	31.8 (a) Licenses issued under this chapter that are available to all applicants pursuant to
993		-	31.9section 342.14, subdivision 1b, paragraph (c), may be freely transferred subject to the prior
994		-	31.10written approval of the office unless the license holder has not received a final site inspection
995		-	31.11or the license holder is a social equity applicant.
996		-	31.12 (b) Licenses issued as social equity licenses pursuant to either section 342.14, subdivision
997		-	31.131b, paragraph (b), or section 342.175, paragraph (b), may only be transferred to another
998		-	31.14social equity applicant for three years after the date on which the office issues the license.
999		-	31.15Three years after the date of issuance, a license holder may transfer a license to any entity.
1000		-	31.16Transfer of a license that was issued as a social equity license must be reviewed by the
1001		-	31.17Division of Social Equity and is subject to the prior written approval of the office.
1002		-	31.18 (c) Preliminary license preapproval approval issued pursuant to section 342.125 342.14,
1003		-	31.19subdivision 5, may not be transferred.
1004		-	31.20 (d) A new license must be obtained when:
1005		-	31.21 (1) the form of the licensee's legal business structure converts or changes to a different
1006		-	31.22type of legal business structure; or
1007		-	31.23 (2) the licensee dissolves; consolidates; reorganizes; undergoes bankruptcy, insolvency,
1008		-	31.24or receivership proceedings; merges with another legal organization; or assigns all or
1009		-	31.25substantially all of its assets for the benefit of creditors.
1010		-	31.26 (e) Licenses must be renewed annually.
1011		-	31.27 (f) License holders may petition the office to adjust the tier of a license issued within a
1012		-	31.28license category if the license holder meets all applicable requirements.
1013		-	31.29 (g) The office by rule may permit the relocation of a licensed cannabis business; permit
1014		-	31.30the relocation of an approved operational location, including a cultivation, manufacturing,
1015		-	31.31processing, or retail location; adopt requirements for the submission of a license relocation
1016		-	31Article 2 Section 1.
1017		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 32.1application; establish standards for the approval of a relocation application; and charge a
1018		-	32.2fee not to exceed $250 for reviewing and processing applications. Relocation of a licensed
1019		-	32.3premises pursuant to this paragraph does not extend or otherwise modify the license term
1020		-	32.4of the license subject to relocation.
1021		-	32.5 Sec. 2. Minnesota Statutes 2024, section 342.14, subdivision 1, is amended to read:
1022		-	32.6 Subdivision 1.Application; contents.(a) The office shall establish procedures for the
1023		-	32.7processing of cannabis licenses issued under this chapter. At a minimum, any application
1024		-	32.8to obtain or renew a cannabis license shall include the following information, if applicable:
1025		-	32.9 (1) the name, address, and date of birth of the applicant;
1026		-	32.10 (2) the disclosure of ownership and control required under paragraph (b);
1027		-	32.11 (3) the disclosure of whether the applicant or, if the applicant is a business, any officer,
1028		-	32.12director, manager, and general partner of the business has ever filed for bankruptcy;
1029		-	32.13 (4) the address and legal property description of the business, if applicable, except an
1030		-	32.14applicant is not required to secure a physical premises for the business at the time of
1031		-	32.15application;
1032		-	32.16 (5) a general description of the location or locations that the applicant plans to operate,
1033		-	32.17including the planned square feet of space for cultivation, wholesaling, and retailing, as
1034		-	32.18applicable;
1035		-	32.19 (6) a copy of the security plan, including security monitoring, security equipment, and
1036		-	32.20facility maps if applicable, except an applicant is not required to secure a physical premises
1037		-	32.21for the business at the time of application;
1038		-	32.22 (7) proof of trade name registration;
1039		-	32.23 (8) a copy of the applicant's business plan showing the expected size of the business;
1040		-	32.24anticipated growth; the methods of record keeping; the knowledge and experience of the
1041		-	32.25applicant and any officer, director, manager, and general partner of the business; the
1042		-	32.26environmental plan; and other relevant financial and operational components;
1043		-	32.27 (9) standard operating procedures for:
1044		-	32.28 (i) quality assurance;
1045		-	32.29 (ii) inventory control, storage, and diversion prevention; and
1046		-	32.30 (iii) accounting and tax compliance;
1047		-	32Article 2 Sec. 2.
1048		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 33.1 (10) an attestation signed by a bona fide labor organization stating that the applicant has
1049		-	33.2entered into a labor peace agreement;
1050		-	33.3 (11) a description of any training and education that the applicant will provide to
1051		-	33.4employees of the business;
1052		-	33.5 (12) a disclosure of any violation of a license agreement or a federal, state, or local law
1053		-	33.6or regulation committed by the applicant or any true party of interest in the applicant's
1054		-	33.7business that is relevant to business and working conditions;
1055		-	33.8 (13) certification that the applicant will comply with the requirements of this chapter;
1056		-	33.9 (14) identification of one or more controlling persons or managerial employees as agents
1057		-	33.10who shall be responsible for dealing with the office on all matters;
1058		-	33.11 (15) a statement that the applicant agrees to respond to the office's supplemental requests
1059		-	33.12for information; and
1060		-	33.13 (16) a release of information for the applicant and every true party of interest in the
1061		-	33.14applicant's business license for the office to perform the background checks required under
1062		-	33.15section 342.15.;
1063		-	33.16 (17) proof that the applicant is a social equity applicant; and
1064		-	33.17 (18) an attestation that the applicant's business policies governing business operations
1065		-	33.18comply with this chapter.
1066		-	33.19 (b) An applicant must file and update as necessary a disclosure of ownership and control
1067		-	33.20identifying any true party of interest as defined in section 342.185, subdivision 1, paragraph
1068		-	33.21(g). The office shall establish the contents of the disclosure. Except as provided in paragraph
1069		-	33.22(f) (d), the disclosure shall, at a minimum, include the following:
1070		-	33.23 (1) the management structure, ownership, and control of the applicant or license holder,
1071		-	33.24including the name of each cooperative member, officer, director, manager, general partner,
1072		-	33.25or business entity; the office or position held by each person; each person's percentage
1073		-	33.26ownership interest, if any; and, if the business has a parent company, the name of each
1074		-	33.27owner, board member, and officer of the parent company and the owner's, board member's,
1075		-	33.28or officer's percentage ownership interest in the parent company and the cannabis business;
1076		-	33.29 (2) a statement from the applicant and, if the applicant is a business, from every officer,
1077		-	33.30director, manager, and general partner of the business, indicating whether that person has
1078		-	33.31previously held, or currently holds, an ownership interest in a cannabis business in Minnesota,
1079		-	33.32any other state or territory of the United States, or any other country;
1080		-	33Article 2 Sec. 2.
1081		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 34.1 (3) if the applicant is a corporation, copies of the applicant's articles of incorporation
1082		-	34.2and bylaws and any amendments to the applicant's articles of incorporation or bylaws;
1083		-	34.3 (4) copies of any partnership agreement, operating agreement, or shareholder agreement;
1084		-	34.4 (5) copies of any promissory notes, security instruments, or other similar agreements;
1085		-	34.5 (6) an explanation detailing the funding sources used to finance the business;
1086		-	34.6 (7) a list of operating and investment accounts for the business, including any applicable
1087		-	34.7financial institution and account number; and
1088		-	34.8 (8) a list of each outstanding loan and financial obligation obtained for use in the business,
1089		-	34.9including the loan amount, loan terms, and name and address of the creditor.
1090		-	34.10 (c) An application may include:
1091		-	34.11 (1) proof that the applicant is a social equity applicant;
1092		-	34.12 (2) a description of the training and education that will be provided to any employee;
1093		-	34.13or
1094		-	34.14 (3) a copy of business policies governing operations to ensure compliance with this
1095		-	34.15chapter.
1096		-	34.16 (d) (c) Commitments made by an applicant in its application, including but not limited
1097		-	34.17to the maintenance of a labor peace agreement, shall be an ongoing material condition of
1098		-	34.18maintaining and renewing the license.
1099		-	34.19 (e) An application on behalf of a corporation or association shall be signed by at least
1100		-	34.20two officers or managing agents of that entity.
1101		-	34.21 (f) (d) The office may establish exceptions to the disclosures required under paragraph
1102		-	34.22(b) for members of a cooperative who hold less than a five percent ownership interest in
1103		-	34.23the cooperative.
1104		-	34.24Sec. 3. Minnesota Statutes 2024, section 342.14, subdivision 3, is amended to read:
1105		-	34.25 Subd. 3.Review.(a) After an applicant submits an application that contains all required
1106		-	34.26information and pays the applicable licensing application fee, the office must review the
1107		-	34.27application.
1108		-	34.28 (b) The office may deny an application if:
1109		-	34.29 (1) the application is incomplete;
1110		-	34Article 2 Sec. 3.
1111		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 35.1 (2) the application contains a materially false statement about the applicant or omits
1112		-	35.2information required under subdivision 1;
1113		-	35.3 (3) the applicant does not meet the qualifications under section 342.16;
1114		-	35.4 (4) the applicant is prohibited from holding the license under section 342.18, subdivision
1115		-	35.52;
1116		-	35.6 (5) the application does not meet the minimum requirements under section 342.18,
1117		-	35.7subdivision 3;
1118		-	35.8 (6) the applicant fails to pay the applicable application fee;
1119		-	35.9 (7) the application was not submitted by the application deadline;
1120		-	35.10 (8) the applicant submitted more than one application for a license type; or
1121		-	35.11 (9) the office determines that the applicant would be prohibited from holding a license
1122		-	35.12for any other reason.
1123		-	35.13 (c) If the office denies an application, the office must notify the applicant of the denial
1124		-	35.14and the basis for the denial.
1125		-	35.15 (d) The office may request additional information from any applicant if the office
1126		-	35.16determines that the information is necessary to review or process the application. If the
1127		-	35.17applicant does not provide the additional requested information within 14 calendar days of
1128		-	35.18the office's request for information, the office may deny the application.
1129		-	35.19 (e) An applicant whose application is not denied under this subdivision is a qualified
1130		-	35.20applicant.
1131		-	35.21Sec. 4. Minnesota Statutes 2024, section 342.14, subdivision 6, is amended to read:
1132		-	35.22 Subd. 6.Completed application; final authorization; issuance of license.(a) Within
1133		-	35.2318 months of receiving notice of preliminary license approval, an applicant must provide:
1134		-	35.24 (1) the address and legal property description of the location where the business will
1135		-	35.25operate;
1136		-	35.26 (2) the name of the local unit of government where the business will be located; and
1137		-	35.27 (3) if applicable, an updated description of the location where the business will operate,
1138		-	35.28an updated security plan, and any other additional information required by the office.
1139		-	35.29 (b) Upon receipt of the information required under paragraph (a) from an applicant that
1140		-	35.30has received preliminary license approval, the office must:
1141		-	35Article 2 Sec. 4.
1142		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 36.1 (1) forward a copy of the application to the local unit of government in which the business
1143		-	36.2operates or intends to operate with a form for certification as to whether a proposed cannabis
1144		-	36.3business complies with local zoning ordinances and, if applicable, whether the proposed
1145		-	36.4business complies with the state fire code and building code;
1146		-	36.5 (2) schedule a site inspection; and
1147		-	36.6 (3) require the applicant to pay the applicable license fee.
1148		-	36.7 (c) The office may deny final authorization if:
1149		-	36.8 (1) an applicant fails to submit any required information;
1150		-	36.9 (2) the applicant submits a materially false statement about the applicant or fails to
1151		-	36.10provide any required information;
1152		-	36.11 (3) the office confirms that the cannabis business for which the office granted a
1153		-	36.12preliminary license preapproval approval does not meet local zoning and land use laws;
1154		-	36.13 (4) the applicant fails to pay the applicable license fee; or
1155		-	36.14 (5) the office determines that the applicant is disqualified from holding the license or
1156		-	36.15would operate in violation of the provisions of this chapter.
1157		-	36.16 (d) Within 90 days of receiving the information required under paragraph (a) and the
1158		-	36.17results of any required background check, the office shall grant final authorization and issue
1159		-	36.18the appropriate license or send the applicant a notice of rejection setting forth specific
1160		-	36.19reasons that the office did not approve the application.
1161		-	36.20Sec. 5. Minnesota Statutes 2024, section 342.151, subdivision 2, is amended to read:
1162		-	36.21 Subd. 2.Criminal history check.A license holder cannabis business may employ or
1163		-	36.22contract with as many unlicensed individuals as may be necessary, provided that the license
1164		-	36.23holder cannabis business is at all times accountable for the good conduct of every individual
1165		-	36.24employed by or contracted with the license holder cannabis business. Before hiring an
1166		-	36.25individual as a cannabis worker, the license holder cannabis business must submit to the
1167		-	36.26Bureau of Criminal Apprehension the individual's full set of fingerprints and written consent
1168		-	36.27for the bureau to conduct a state and national criminal history check. The bureau may
1169		-	36.28exchange an individual's fingerprints with the Federal Bureau of Investigation. The Bureau
1170		-	36.29of Criminal Apprehension must determine whether the individual is qualified to be employed
1171		-	36.30as a cannabis worker and must notify the license holder cannabis business of the bureau's
1172		-	36.31determination. The license holder cannabis business must not employ an individual who is
1173		-	36.32disqualified from being employed as a cannabis worker.
1174		-	36Article 2 Sec. 5.
1175		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 37.1 Sec. 6. Minnesota Statutes 2024, section 342.151, subdivision 3, is amended to read:
1176		-	37.2 Subd. 3.Disqualification.(a) A license holder cannabis business must not employ an
1177		-	37.3individual as a cannabis worker if the individual has been convicted of any of the following
1178		-	37.4crimes that would constitute a felony:
1179		-	37.5 (1) human trafficking;
1180		-	37.6 (2) noncannabis controlled substance crimes in the first or second degree;
1181		-	37.7 (3) labor trafficking;
1182		-	37.8 (4) fraud;
1183		-	37.9 (5) embezzlement;
1184		-	37.10 (6) extortion;
1185		-	37.11 (7) money laundering; or
1186		-	37.12 (8) insider trading;
1187		-	37.13if committed in this state or any other jurisdiction for which a full pardon or similar relief
1188		-	37.14has not been granted.
1189		-	37.15 (b) A license holder cannabis business must not employ an individual as a cannabis
1190		-	37.16worker if the individual made any false statement in an application for employment.
1191		-	37.17Sec. 7. Minnesota Statutes 2024, section 342.17, is amended to read:
1192		-	37.18 342.17 SOCIAL EQUITY APPLICANTS.
1193		-	37.19 (a) An applicant qualifies as a social equity applicant if the applicant:
1194		-	37.20 (1) was found delinquent for, received a stay of adjudication for, or was convicted of
1195		-	37.21an offense involving the possession or sale of cannabis or marijuana prior to May 1, 2023;
1196		-	37.22 (2) had a parent, guardian, child, spouse, or dependent who was convicted of an offense
1197		-	37.23involving the possession or sale of cannabis or marijuana prior to May 1, 2023;
1198		-	37.24 (3) was a dependent of an individual who was convicted of an offense involving the
1199		-	37.25possession or sale of cannabis or marijuana prior to May 1, 2023;
1200		-	37.26 (4) is a military veteran, including a service-disabled veteran, current or former member
1201		-	37.27of the national guard;
1202		-	37.28 (5) is a military veteran or current or former member of the national guard who lost
1203		-	37.29honorable status due to an offense involving the possession or sale of cannabis or marijuana;
1204		-	37Article 2 Sec. 7.
1205		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 38.1 (6) has been a resident for the last five years of one or more subareas, such as census
1206		-	38.2tracts or neighborhoods:
1207		-	38.3 (i) that experienced a disproportionately large amount of cannabis enforcement as
1208		-	38.4determined by the study conducted by the office pursuant to section 342.04, paragraph (b),
1209		-	38.5or another report based on federal or state data on arrests or convictions;
1210		-	38.6 (ii) where the poverty rate was 20 percent or more;
1211		-	38.7 (iii) where the median family income did not exceed 80 percent of the statewide median
1212		-	38.8family income or, if in a metropolitan area, did not exceed the greater of 80 percent of the
1213		-	38.9statewide median family income or 80 percent of the median family income for that
1214		-	38.10metropolitan area;
1215		-	38.11 (iv) where at least 20 percent of the households receive assistance through the
1216		-	38.12Supplemental Nutrition Assistance Program; or
1217		-	38.13 (v) where the population has a high level of vulnerability according to the Centers for
1218		-	38.14Disease Control and Prevention and Agency for Toxic Substances and Disease Registry
1219		-	38.15(CDC/ATSDR) Social Vulnerability Index; or
1220		-	38.16 (7) has participated in the business operation of a farm for at least three years and
1221		-	38.17currently provides the majority of the day-to-day physical labor and management of a farm
1222		-	38.18that had gross farm sales of at least $5,000 but not more than $100,000 in the previous year.
1223		-	38.19 (b) The qualifications described in paragraph (a) apply to each individual applicant or,
1224		-	38.20in the case of a business entity, apply to at least 65 51 percent of the controlling ownership
1225		-	38.21of the business entity.
1226		-	38.22 EFFECTIVE DATE.The amendment to paragraph (a), clause (1), is effective August
1227		-	38.231, 2025. The amendment to paragraph (b) is effective July 1, 2026.
1228		-	38.24Sec. 8. Minnesota Statutes 2024, section 342.22, subdivision 3, is amended to read:
1229		-	38.25 Subd. 3.Issuance of registration.(a) A local unit of government shall issue a retail
1230		-	38.26registration to a cannabis microbusiness with a retail operations endorsement, cannabis
1231		-	38.27mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis
1232		-	38.28combination business operating a retail location, or lower-potency hemp edible retailer that:
1233		-	38.29 (1) has a valid license or preliminary license preapproval approval issued by the office;
1234		-	38.30 (2) has paid the registration fee or renewal fee pursuant to subdivision 2;
1235		-	38Article 2 Sec. 8.
1236		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 39.1 (3) is found to be in compliance with the requirements of this chapter at any preliminary
1237		-	39.2compliance check that the local unit of government performs; and
1238		-	39.3 (4) if applicable, is current on all property taxes and assessments at the location where
1239		-	39.4the retail establishment is located.
1240		-	39.5 (b) Before issuing a retail registration, the local unit of government may conduct a
1241		-	39.6preliminary compliance check to ensure that the cannabis business or hemp business is in
1242		-	39.7compliance with any applicable local ordinance established pursuant to section 342.13.
1243		-	39.8 (c) A local unit of government shall renew the retail registration of a cannabis business
1244		-	39.9or hemp business when the office renews the license of the cannabis business or hemp
1245		-	39.10business.
1246		-	39.11 (d) A retail registration issued under this section may not be transferred.
1247		-	39.12Sec. 9. Minnesota Statutes 2024, section 342.28, subdivision 1, is amended to read:
1248		-	39.13 Subdivision 1.Authorized actions.A cannabis microbusiness license, consistent with
1249		-	39.14the specific license endorsement or endorsements, entitles the license holder to perform any
1250		-	39.15or all of the following within the limits established by this section:
1251		-	39.16 (1) grow cannabis plants from seed or immature plant to mature plant and harvest
1252		-	39.17cannabis flower from a mature plant;
1253		-	39.18 (2) make cannabis concentrate;
1254		-	39.19 (3) make hemp concentrate, including hemp concentrate with a delta-9
1255		-	39.20tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
1256		-	39.21 (4) manufacture artificially derived cannabinoids;
1257		-	39.22 (5) manufacture adult-use cannabis products, lower-potency hemp edibles, and
1258		-	39.23hemp-derived consumer products for public consumption;
1259		-	39.24 (6) purchase immature cannabis plants and seedlings and, cannabis flower, cannabis
1260		-	39.25products, lower-potency hemp edibles, and hemp-derived consumer products from another
1261		-	39.26cannabis microbusiness, a cannabis mezzobusiness, a cannabis cultivator, a cannabis
1262		-	39.27manufacturer, or a cannabis wholesaler, a lower-potency hemp edible manufacturer, or a
1263		-	39.28lower-potency hemp edible wholesaler;
1264		-	39.29 (7) purchase hemp plant parts and propagules from an industrial hemp grower licensed
1265		-	39.30under chapter 18K;
1266		-	39Article 2 Sec. 9.
1267		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 40.1 (8) purchase hemp concentrate from an industrial hemp processor licensed under chapter
1268		-	40.218K;
1269		-	40.3 (9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids
1270		-	40.4from another cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer,
1271		-	40.5or a cannabis wholesaler for use in manufacturing adult-use cannabis products, lower-potency
1272		-	40.6hemp edibles, or hemp-derived consumer products;
1273		-	40.7 (10) package and label adult-use cannabis flower, adult-use cannabis products,
1274		-	40.8lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
1275		-	40.9 (11) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use
1276		-	40.10cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and
1277		-	40.11other products authorized by law to other cannabis businesses and to customers;
1278		-	40.12 (12) operate an establishment that permits on-site consumption of edible cannabis
1279		-	40.13products and lower-potency hemp edibles; and
1280		-	40.14 (13) perform other actions approved by the office.
1281		-	40.15Sec. 10. Minnesota Statutes 2024, section 342.28, subdivision 8, is amended to read:
1282		-	40.16 Subd. 8.Production of customer consumer products endorsement.A cannabis
1283		-	40.17microbusiness that manufactures edible cannabis products, lower-potency hemp products,
1284		-	40.18or hemp-derived consumer products must comply with the requirements in section 342.26,
1285		-	40.19subdivisions 2 and 4.
1286		-	40.20Sec. 11. Minnesota Statutes 2024, section 342.29, subdivision 1, is amended to read:
1287		-	40.21 Subdivision 1.Authorized actions.A cannabis mezzobusiness license, consistent with
1288		-	40.22the specific license endorsement or endorsements, entitles the license holder to perform any
1289		-	40.23or all of the following within the limits established by this section:
1290		-	40.24 (1) grow cannabis plants from seed or immature plant to mature plant and harvest
1291		-	40.25cannabis flower from a mature plant for use as adult-use cannabis flower or for use in
1292		-	40.26adult-use cannabis products;
1293		-	40.27 (2) grow cannabis plants from seed or immature plant to mature plant and harvest
1294		-	40.28cannabis flower from a mature plant for use as medical cannabis flower or for use in medical
1295		-	40.29cannabinoid products;
1296		-	40.30 (3) make cannabis concentrate;
1297		-	40Article 2 Sec. 11.
1298		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 41.1 (4) make hemp concentrate, including hemp concentrate with a delta-9
1299		-	41.2tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
1300		-	41.3 (5) manufacture artificially derived cannabinoids;
1301		-	41.4 (6) manufacture adult-use cannabis products, lower-potency hemp edibles, and
1302		-	41.5hemp-derived consumer products for public consumption;
1303		-	41.6 (7) process medical cannabinoid products;
1304		-	41.7 (8) purchase immature cannabis plants and seedlings and, cannabis flower, cannabis
1305		-	41.8products, lower-potency hemp edibles, and hemp-derived consumer products from a cannabis
1306		-	41.9microbusiness, another cannabis mezzobusiness, a cannabis cultivator, a cannabis
1307		-	41.10manufacturer, or a cannabis wholesaler, a lower-potency hemp edible manufacturer, or a
1308		-	41.11lower-potency hemp edible wholesaler;
1309		-	41.12 (9) purchase cannabis concentrate, hemp concentrate, and synthetically artificially derived
1310		-	41.13cannabinoids from a cannabis microbusiness, another cannabis mezzobusiness, a cannabis
1311		-	41.14manufacturer, or a cannabis wholesaler for use in manufacturing adult-use cannabis products,
1312		-	41.15lower-potency hemp edibles, or hemp-derived consumer products;
1313		-	41.16 (10) purchase hemp plant parts and propagules from a licensed hemp grower licensed
1314		-	41.17under chapter 18K;
1315		-	41.18 (11) purchase hemp concentrate from an industrial hemp processor licensed under chapter
1316		-	41.1918K;
1317		-	41.20 (12) package and label adult-use cannabis flower, adult-use cannabis products,
1318		-	41.21lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
1319		-	41.22 (13) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use
1320		-	41.23cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and
1321		-	41.24other products authorized by law to other cannabis businesses and to customers; and
1322		-	41.25 (14) perform other actions approved by the office.
1323		-	41.26Sec. 12. Minnesota Statutes 2024, section 342.29, subdivision 7, is amended to read:
1324		-	41.27 Subd. 7.Production of customer consumer products endorsement.A cannabis
1325		-	41.28mezzobusiness that manufactures edible cannabis products, lower-potency hemp products,
1326		-	41.29or hemp-derived consumer products must comply with the requirements in section 342.26,
1327		-	41.30subdivisions 2 and 4.
1328		-	41Article 2 Sec. 12.
1329		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 42.1 Sec. 13. Minnesota Statutes 2024, section 342.30, subdivision 1, is amended to read:
1330		-	42.2 Subdivision 1.Authorized actions.A cannabis cultivator license entitles the license
1331		-	42.3holder to:
1332		-	42.4 (1) grow cannabis plants within the approved amount of space from seed or immature
1333		-	42.5plant to mature plant,;
1334		-	42.6 (2) harvest cannabis flower from a mature plant,;
1335		-	42.7 (3) package and label immature cannabis plants and seedlings and cannabis flower for
1336		-	42.8sale to other cannabis businesses,;
1337		-	42.9 (4) sell immature cannabis plants and seedlings and cannabis flower to other cannabis
1338		-	42.10businesses;
1339		-	42.11 (5) transport cannabis flower to a cannabis manufacturer located on the same premises,;
1340		-	42.12and
1341		-	42.13 (6) perform other actions approved by the office.
1342		-	42.14Sec. 14. Minnesota Statutes 2024, section 342.32, subdivision 1, is amended to read:
1343		-	42.15 Subdivision 1.Authorized actions.A cannabis retailer license entitles the license holder
1344		-	42.16to:
1345		-	42.17 (1) purchase immature cannabis plants and seedlings, cannabis flower, cannabis products,
1346		-	42.18lower-potency hemp edibles, and hemp-derived consumer products from cannabis
1347		-	42.19microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers,
1348		-	42.20and cannabis wholesalers;
1349		-	42.21 (2) purchase lower-potency hemp edibles from a licensed lower-potency hemp edible
1350		-	42.22manufacturer or lower-potency hemp edible wholesaler;
1351		-	42.23 (3) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use
1352		-	42.24cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and
1353		-	42.25other products authorized by law to customers; and
1354		-	42.26 (4) perform other actions approved by the office.
1355		-	42.27Sec. 15. Minnesota Statutes 2024, section 342.32, subdivision 4, is amended to read:
1356		-	42.28 Subd. 4.Multiple licenses; limits.(a) A person, cooperative, or business holding a
1357		-	42.29cannabis retailer license may also hold a cannabis delivery service license and a cannabis
1358		-	42.30event organizer license.
1359		-	42Article 2 Sec. 15.
1360		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 43.1 (b) Except as provided in paragraph (a) and subdivision 5, no person, cooperative, or
1361		-	43.2business holding a cannabis retailer license may own or operate any other cannabis business
1362		-	43.3or hemp business.
1363		-	43.4 (c) No person, cooperative, or business may hold a license to own or operate more than
1364		-	43.5one cannabis retail business in one city and three retail businesses in one county.
1365		-	43.6 (d) The office by rule may limit the number of cannabis retailer licenses a person,
1366		-	43.7cooperative, or business may hold.
1367		-	43.8 (e) For purposes of this subdivision, a restriction on the number or type of license a
1368		-	43.9business may hold applies to every cooperative member or every director, manager, and
1369		-	43.10general partner of a cannabis business.
1370		-	43.11Sec. 16. Minnesota Statutes 2024, section 342.32, subdivision 5, is amended to read:
1371		-	43.12 Subd. 5.Municipal or county cannabis store.A city or county may establish, own,
1372		-	43.13and operate a municipal cannabis store subject to the restrictions in this chapter.
1373		-	43.14Notwithstanding any law to the contrary, a city or county that establishes, owns, or operates
1374		-	43.15a municipal cannabis store may also hold a lower-potency hemp edible retailer license.
1375		-	43.16Sec. 17. Minnesota Statutes 2024, section 342.33, subdivision 1, is amended to read:
1376		-	43.17 Subdivision 1.Authorized actions.A cannabis wholesaler license entitles the license
1377		-	43.18holder to:
1378		-	43.19 (1) purchase immature cannabis plants and seedlings, cannabis flower, cannabis products,
1379		-	43.20lower-potency hemp edibles, and hemp-derived consumer products from cannabis
1380		-	43.21microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers,
1381		-	43.22and cannabis microbusinesses lower-potency hemp edible manufacturers;
1382		-	43.23 (2) purchase hemp plant parts and propagules from industrial hemp growers licensed
1383		-	43.24under chapter 18K;
1384		-	43.25 (3) purchase hemp concentrate from an industrial hemp processor licensed under chapter
1385		-	43.2618K;
1386		-	43.27 (4) sell immature cannabis plants and seedlings, cannabis flower, cannabis products,
1387		-	43.28lower-potency hemp edibles, and hemp-derived consumer products to cannabis
1388		-	43.29microbusinesses, cannabis mezzobusinesses, cannabis manufacturers, and cannabis retailers;
1389		-	43.30 (5) sell lower-potency hemp edibles to lower-potency hemp edible retailers;
1390		-	43Article 2 Sec. 17.
1391		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 44.1 (6) import hemp-derived consumer products and lower-potency hemp edibles that contain
1392		-	44.2hemp concentrate or artificially derived cannabinoids that are derived from hemp plants or
1393		-	44.3hemp plant parts; and
1394		-	44.4 (7) perform other actions approved by the office.
1395		-	44.5 Sec. 18. Minnesota Statutes 2024, section 342.36, subdivision 6, is amended to read:
1396		-	44.6 Subd. 6.Multiple employees; secured vehicles; delivery routes.All cannabis transporter
1397		-	44.7vehicles transporting immature cannabis plants and seedlings, cannabis flower, cannabis
1398		-	44.8products, artificially derived cannabinoids, hemp plant parts, hemp concentrate,
1399		-	44.9lower-potency hemp edibles, or hemp-derived consumer products must be staffed with a
1400		-	44.10minimum of two employees (1) secured by turning off the ignition, locking all doors and
1401		-	44.11storage compartments, and removing the operating keys or device, or (2) attended by a
1402		-	44.12cannabis transporter employee at all times. If there are multiple team members staffing an
1403		-	44.13unsecured transport vehicle, at least one delivery team member shall remain with the motor
1404		-	44.14vehicle at all times that the motor vehicle contains immature cannabis plants and seedlings,
1405		-	44.15cannabis flower, cannabis products, artificially derived cannabinoids, hemp plant parts,
1406		-	44.16hemp concentrate, lower-potency hemp edibles, or hemp-derived consumer products. A
1407		-	44.17cannabis transporter must not be required to randomize delivery times and routes or staff
1408		-	44.18cannabis transport vehicles with multiple employees.
1409		-	44.19Sec. 19. Minnesota Statutes 2024, section 342.37, is amended by adding a subdivision to
1410		-	44.20read:
1411		-	44.21 Subd. 2a.Cannabis testing facility licenses.(a) Pending an applicant's accreditation
1412		-	44.22by a laboratory accrediting organization approved by the office, the office may issue or
1413		-	44.23renew a cannabis testing facility license for an applicant that is a person, cooperative, or
1414		-	44.24business if the applicant:
1415		-	44.25 (1) submits documentation to the office demonstrating that the applicant has a signed
1416		-	44.26contract with a laboratory accreditation organization approved by the office, has scheduled
1417		-	44.27an audit, and is making progress toward accreditation by a laboratory accrediting organization
1418		-	44.28approved by the office according to the standards of the most recent edition of ISO/IEC
1419		-	44.2917025: General Requirements for the Competence of Testing and Calibration Laboratories;
1420		-	44.30 (2) passes a final site inspection conducted by the office; and
1421		-	44.31 (3) meets all other licensing requirements according to chapter 342 and Minnesota Rules.
1422		-	44Article 2 Sec. 19.
1423		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 45.1 (b) After receiving a license under this section, a license holder may operate a cannabis
1424		-	45.2testing facility up to one year with pending accreditation status.
1425		-	45.3 (c) If after one year a license holder continues to have pending accreditation status, the
1426		-	45.4license holder may apply for a onetime extension to continue operations for up to six months.
1427		-	45.5The office may grant an extension under this paragraph to a license holder if the license
1428		-	45.6holder:
1429		-	45.7 (1) passes a follow-up site inspection conducted by the office;
1430		-	45.8 (2) submits an initial audit report from a laboratory accrediting organization approved
1431		-	45.9by the office; and
1432		-	45.10 (3) submits any additional information requested by the office.
1433		-	45.11 (d) The office may revoke a cannabis testing facility license held by a license holder
1434		-	45.12with pending accreditation status if the office determines or has reason to believe that the
1435		-	45.13license holder:
1436		-	45.14 (1) is not making progress toward accreditation; or
1437		-	45.15 (2) has violated a cannabis testing requirement, an ownership requirement, or an
1438		-	45.16operational requirement in chapter 342 or Minnesota Rules.
1439		-	45.17 (e) The office must not issue or renew a cannabis testing facility license under this
1440		-	45.18subdivision for a license holder if the license holder's accreditation has been suspended or
1441		-	45.19revoked by a laboratory accrediting organization.
1442		-	45.20Sec. 20. Minnesota Statutes 2024, section 342.37, is amended by adding a subdivision to
1443		-	45.21read:
1444		-	45.22 Subd. 2b.Loss of accreditation.(a) A license holder must report loss of accreditation
1445		-	45.23to the office within 24 hours of receiving notice of the loss of accreditation.
1446		-	45.24 (b) The office must immediately revoke a license holder's license upon receiving notice
1447		-	45.25that the license holder has lost accreditation.
1448		-	45.26Sec. 21. Minnesota Statutes 2024, section 342.43, is amended by adding a subdivision to
1449		-	45.27read:
1450		-	45.28 Subd. 3.Exception; municipal or county licenses.Notwithstanding any law to the
1451		-	45.29contrary, a city or county that establishes, owns, or operates a municipal cannabis store may
1452		-	45.30also hold a lower-potency hemp edible retailer license.
1453		-	45Article 2 Sec. 21.
1454		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 46.1 Sec. 22. Minnesota Statutes 2024, section 342.61, subdivision 4, is amended to read:
1455		-	46.2 Subd. 4.Testing of samples; disclosures.(a) On a schedule determined by the office,
1456		-	46.3every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
1457		-	46.4manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
1458		-	46.5hemp edible manufacturer, or medical cannabis combination business shall make each batch
1459		-	46.6of cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency
1460		-	46.7hemp edibles, or hemp-derived consumer products grown, manufactured, or imported by
1461		-	46.8the cannabis business or hemp business available to a cannabis testing facility.
1462		-	46.9 (b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
1463		-	46.10manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
1464		-	46.11hemp edible manufacturer, or medical cannabis combination business must disclose all
1465		-	46.12known information regarding pesticides, fertilizers, solvents, or other foreign materials,
1466		-	46.13including but not limited to catalysts used in creating artificially derived cannabinoids,
1467		-	46.14applied or added to the batch of cannabis flower, cannabis products, artificially derived
1468		-	46.15cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products subject to
1469		-	46.16testing. Disclosure must be made to the cannabis testing facility and must include information
1470		-	46.17about all applications by any person, whether intentional or accidental.
1471		-	46.18 (c) The A cannabis testing facility business shall select one or more representative
1472		-	46.19samples from each batch, test the samples for the presence of contaminants, and test the
1473		-	46.20samples for potency and homogeneity and to allow the cannabis flower, cannabis product,
1474		-	46.21artificially derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer
1475		-	46.22product to be accurately labeled with its cannabinoid profile. Testing for contaminants must
1476		-	46.23include testing for residual solvents, foreign material, microbiological contaminants, heavy
1477		-	46.24metals, pesticide residue, mycotoxins, and any items identified pursuant to paragraph (b),
1478		-	46.25and may include testing for other contaminants. A cannabis testing facility must destroy or
1479		-	46.26return to the cannabis business or hemp business any part of the sample that remains after
1480		-	46.27testing.
1481		-	46.28Sec. 23. Minnesota Statutes 2024, section 342.63, subdivision 2, is amended to read:
1482		-	46.29 Subd. 2.Content of label; cannabis.All cannabis flower and hemp-derived consumer
1483		-	46.30products that consist of hemp plant parts sold to customers or patients must have affixed
1484		-	46.31on the packaging or container of the cannabis flower or hemp-derived consumer product a
1485		-	46.32label that contains at least the following information:
1486		-	46Article 2 Sec. 23.
1487		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 47.1 (1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
1488		-	47.2cannabis cultivator, medical cannabis combination business, or industrial hemp grower
1489		-	47.3where the cannabis flower or hemp plant part was cultivated;
1490		-	47.4 (2) the net weight or volume of cannabis flower or hemp plant parts in the package or
1491		-	47.5container;
1492		-	47.6 (3) the batch number;
1493		-	47.7 (4) the cannabinoid profile;
1494		-	47.8 (5) a universal symbol established by the office indicating that the package or container
1495		-	47.9contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a
1496		-	47.10hemp-derived consumer product;
1497		-	47.11 (6) verification that the cannabis flower or hemp plant part was tested according to
1498		-	47.12section 342.61 and that the cannabis flower or hemp plant part complies with the applicable
1499		-	47.13standards;
1500		-	47.14 (7) information on the usage of the cannabis flower or hemp-derived consumer product;
1501		-	47.15 (8) the following statement: "Keep this product out of reach of children."; and
1502		-	47.16 (9) any other statements or information required by the office.
1503		-	47.17Sec. 24. Minnesota Statutes 2024, section 342.63, subdivision 3, is amended to read:
1504		-	47.18 Subd. 3.Content of label; cannabinoid products.(a) All cannabis products,
1505		-	47.19lower-potency hemp edibles, hemp concentrate, hemp-derived consumer products other
1506		-	47.20than products subject to the requirements under subdivision 2, medical cannabinoid products,
1507		-	47.21and hemp-derived topical products sold to customers or patients must have affixed to the
1508		-	47.22packaging or container of the cannabis product a label that contains at least the following
1509		-	47.23information:
1510		-	47.24 (1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
1511		-	47.25cannabis cultivator, medical cannabis combination business, or industrial hemp grower that
1512		-	47.26cultivated the cannabis flower or hemp plant parts used in the cannabis product,
1513		-	47.27lower-potency hemp edible, hemp-derived consumer product, or medical cannabinoid
1514		-	47.28product;
1515		-	47.29 (2) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
1516		-	47.30cannabis manufacturer, lower-potency hemp edible manufacturer, medical cannabis
1517		-	47.31combination business, or industrial hemp grower that manufactured the cannabis concentrate,
1518		-	47.32hemp concentrate, or artificially derived cannabinoid and, if different, the name and license
1519		-	47Article 2 Sec. 24.
1520		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 48.1number of the cannabis microbusiness, cannabis mezzobusiness, cannabis manufacturer,
1521		-	48.2lower-potency hemp edible manufacturer, or medical cannabis combination business that
1522		-	48.3manufactured the product;
1523		-	48.4 (3) the net weight or volume of the cannabis product, lower-potency hemp edible, or
1524		-	48.5hemp-derived consumer product in the package or container;
1525		-	48.6 (4) the type of cannabis product, lower-potency hemp edible, or hemp-derived consumer
1526		-	48.7product;
1527		-	48.8 (5) the batch number;
1528		-	48.9 (6) the serving size;
1529		-	48.10 (7) the cannabinoid profile per serving and in total;
1530		-	48.11 (8) a list of ingredients;
1531		-	48.12 (9) a universal symbol established by the office indicating that the package or container
1532		-	48.13contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a
1533		-	48.14hemp-derived consumer product;
1534		-	48.15 (10) a warning symbol developed by the office in consultation with the commissioner
1535		-	48.16of health and the Minnesota Poison Control System that:
1536		-	48.17 (i) is at least three-quarters of an inch tall and six-tenths of an inch wide;
1537		-	48.18 (ii) is in a highly visible color;
1538		-	48.19 (iii) includes a visual element that is commonly understood to mean a person should
1539		-	48.20stop;
1540		-	48.21 (iv) indicates that the product is not for children; and
1541		-	48.22 (v) includes the phone number of the Minnesota Poison Control System;
1542		-	48.23 (11) verification that the cannabis product, lower-potency hemp edible, hemp-derived
1543		-	48.24consumer product, or medical cannabinoid product was tested according to section 342.61
1544		-	48.25and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product,
1545		-	48.26or medical cannabinoid product complies with the applicable standards;
1546		-	48.27 (12) information on the usage of the product;
1547		-	48.28 (13) the following statement: "Keep this product out of reach of children."; and
1548		-	48.29 (14) any other statements or information required by the office.
1549		-	48Article 2 Sec. 24.
1550		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 49.1 (b) The office may by rule establish alternative labeling requirements for lower-potency
1551		-	49.2hemp edibles that are imported into the state if those requirements provide consumers with
1552		-	49.3information that is substantially similar to the information described in paragraph (a).
1553		-	49.4 Sec. 25. Minnesota Statutes 2024, section 342.63, subdivision 6, is amended to read:
1554		-	49.5 Subd. 6.Additional information.(a) A cannabis microbusiness, cannabis mezzobusiness,
1555		-	49.6cannabis retailer, or medical cannabis combination business must provide customers and
1556		-	49.7patients with the following information:
1557		-	49.8 (1) factual information about impairment effects and the expected timing of impairment
1558		-	49.9effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products,
1559		-	49.10lower-potency hemp edibles, and hemp-derived consumer products;
1560		-	49.11 (2) a statement that customers and patients must not operate a motor vehicle or heavy
1561		-	49.12machinery while under the influence of cannabis flower, cannabis products, lower-potency
1562		-	49.13hemp edibles, and hemp-derived consumer products;
1563		-	49.14 (3) resources customers and patients may consult to answer questions about cannabis
1564		-	49.15flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer
1565		-	49.16products, and any side effects and adverse effects;
1566		-	49.17 (4) contact information for the poison control center and a safety hotline or website for
1567		-	49.18customers to report and obtain advice about side effects and adverse effects of cannabis
1568		-	49.19flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer
1569		-	49.20products;
1570		-	49.21 (5) substance use disorder treatment options; and
1571		-	49.22 (6) any other information specified by the office.
1572		-	49.23 (b) A cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or medical
1573		-	49.24cannabis combination business may include the information described in paragraph (a) by:
1574		-	49.25 (1) including the information on the label affixed to the packaging or container of cannabis
1575		-	49.26flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products
1576		-	49.27by:;
1577		-	49.28 (1) (2) posting the information in the premises of the cannabis microbusiness, cannabis
1578		-	49.29mezzobusiness, cannabis retailer, or medical cannabis combination business; or
1579		-	49.30 (2) (3) providing the information on a separate document or pamphlet provided to
1580		-	49.31customers or patients when the customer purchases cannabis flower, a cannabis product, a
1581		-	49.32lower-potency hemp edible, or a hemp-derived consumer product.
1582		-	49Article 2 Sec. 25.
1583		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 50.1 Sec. 26. REPEALER.
1584		-	50.2 Minnesota Statutes 2024, section 342.36, subdivision 5, is repealed.
1585		-	50.3 ARTICLE 3
1586		-	50.4 HEMP BUSINESS REGULATIONS
1587		-	50.5 Section 1. Minnesota Statutes 2024, section 151.72, subdivision 3, is amended to read:
1588		-	50.6 Subd. 3.Sale of cannabinoids derived from hemp.(a) Notwithstanding any other
1589		-	50.7section of this chapter, a product containing nonintoxicating cannabinoids, including an
1590		-	50.8edible cannabinoid product, may be sold for human or animal consumption only if all of
1591		-	50.9the requirements of this section are met. A product sold for human or animal consumption
1592		-	50.10must not contain more than 0.3 percent of any tetrahydrocannabinol and an edible
1593		-	50.11cannabinoid product must not contain an amount of any tetrahydrocannabinol that exceeds
1594		-	50.12the limits established in subdivision 5a, paragraph (f).
1595		-	50.13 (b) A product containing nonintoxicating cannabinoids, other than an edible cannabinoid
1596		-	50.14product, may be sold for human or animal consumption only if it is intended for application
1597		-	50.15externally to a part of the body of a human or animal. Such a product must not be
1598		-	50.16manufactured, marketed, distributed, or intended to be consumed:
1599		-	50.17 (1) by combustion or vaporization of the product and inhalation of smoke, aerosol, or
1600		-	50.18vapor from the product;
1601		-	50.19 (2) through chewing, drinking, or swallowing; or
1602		-	50.20 (3) through injection or application to nonintact skin or a mucous membrane or nonintact
1603		-	50.21skin, except for products applied sublingually.
1604		-	50.22 (c) No other substance extracted or otherwise derived from hemp may be sold for human
1605		-	50.23consumption if the substance is intended:
1606		-	50.24 (1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention
1607		-	50.25of disease in humans or other animals; or
1608		-	50.26 (2) to affect the structure or any function of the bodies of humans or other animals.
1609		-	50.27 (d) No product containing any cannabinoid or tetrahydrocannabinol extracted or otherwise
1610		-	50.28derived from hemp may be sold to any individual who is under the age of 21.
1611		-	50.29 (e) Products that meet the requirements of this section are not controlled substances
1612		-	50.30under section 152.02.
1613		-	50Article 3 Section 1.
1614		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 51.1 (f) Products may be sold for on-site consumption if all of the following conditions are
1615		-	51.2met:
1616		-	51.3 (1) the retailer must also hold an on-sale license issued under chapter 340A;
1617		-	51.4 (2) products, other than products that are intended to be consumed as a beverage, must
1618		-	51.5be served in original packaging, but may be removed from the products' packaging by
1619		-	51.6customers and consumed on site;
1620		-	51.7 (3) products must not be sold to a customer who the retailer knows or reasonably should
1621		-	51.8know is intoxicated;
1622		-	51.9 (4) products must not be permitted to be mixed with an alcoholic beverage; and
1623		-	51.10 (5) products that have been removed from packaging must not be removed from the
1624		-	51.11premises.
1625		-	51.12 (g) Edible cannabinoid products that are intended to be consumed as a beverage may be
1626		-	51.13served outside of the products' packaging if the information that is required to be contained
1627		-	51.14on the label of an edible cannabinoid product is posted or otherwise displayed by the retailer.
1628		-	51.15Sec. 2. Minnesota Statutes 2024, section 151.72, subdivision 5a, is amended to read:
1629		-	51.16 Subd. 5a.Additional requirements for edible cannabinoid products.(a) In addition
1630		-	51.17to the testing and labeling requirements under subdivisions 4 and 5, an edible cannabinoid
1631		-	51.18must meet the requirements of this subdivision.
1632		-	51.19 (b) An edible cannabinoid product must not:
1633		-	51.20 (1) bear the likeness or contain cartoon-like characteristics of a real or fictional person,
1634		-	51.21animal, or fruit that appeals to children;
1635		-	51.22 (2) be modeled after a brand of products primarily consumed by or marketed to children;
1636		-	51.23 (3) be made by applying an extracted or concentrated hemp-derived cannabinoid to a
1637		-	51.24commercially available candy or snack food item;
1638		-	51.25 (4) be substantively similar to a meat food product; poultry food product as defined in
1639		-	51.26section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision
1640		-	51.277;
1641		-	51.28 (5) contain an ingredient, other than a hemp-derived cannabinoid, that is not approved
1642		-	51.29by the United States Food and Drug Administration for use in food;
1643		-	51.30 (6) be packaged in a way that resembles the trademarked, characteristic, or
1644		-	51.31product-specialized packaging of any commercially available food product; or
1645		-	51Article 3 Sec. 2.
1646		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 52.1 (7) be packaged in a container that includes a statement, artwork, or design that could
1647		-	52.2reasonably mislead any person to believe that the package contains anything other than an
1648		-	52.3edible cannabinoid product.
1649		-	52.4 (c) An edible cannabinoid product must be prepackaged in packaging or a container that
1650		-	52.5is child-resistant, tamper-evident, and opaque or placed in packaging or a container that is
1651		-	52.6child-resistant, tamper-evident, and opaque at the final point of sale to a customer. The
1652		-	52.7requirement that packaging be child-resistant does not apply to an edible cannabinoid product
1653		-	52.8that is intended to be consumed as a beverage.
1654		-	52.9 (d) If an edible cannabinoid product, other than a product that is intended to be consumed
1655		-	52.10as a beverage, is intended for more than a single use or contains multiple servings, each
1656		-	52.11serving must be indicated by scoring, wrapping, or other indicators designating the individual
1657		-	52.12serving size that appear on the edible cannabinoid product. If it is not possible to indicate
1658		-	52.13a single serving by scoring or use of another indicator that appears on the product, the edible
1659		-	52.14cannabinoid product may not be packaged in a manner that includes more than a single
1660		-	52.15serving in each container, except that a calibrated dropper, measuring spoon, or similar
1661		-	52.16device for measuring a single serving, when sold with the product, may be used for any
1662		-	52.17edible cannabinoid products that are intended to be combined with food or beverage products
1663		-	52.18prior to consumption.
1664		-	52.19 (e) A label containing at least the following information must be affixed to the packaging
1665		-	52.20or container of all edible cannabinoid products sold to consumers:
1666		-	52.21 (1) the serving size;
1667		-	52.22 (2) the cannabinoid profile per serving and in total;
1668		-	52.23 (3) a list of ingredients, including identification of any major food allergens declared
1669		-	52.24by name; and
1670		-	52.25 (4) the following statement: "Keep this product out of reach of children."
1671		-	52.26 (f) An edible cannabinoid product that is not intended to be consumed as a beverage
1672		-	52.27must not contain more than five milligrams of any tetrahydrocannabinol in a single serving.
1673		-	52.28An edible cannabinoid product, other than a product that is intended to be consumed as a
1674		-	52.29beverage, may and must not contain more than a total of 50 milligrams of any
1675		-	52.30tetrahydrocannabinol per package. An edible cannabinoid product that is intended to be
1676		-	52.31consumed as a beverage may not contain more than two servings per container.
1677		-	52.32 (g) An edible cannabinoid product that is intended to be consumed as a beverage must
1678		-	52.33not contain more than ten milligrams of any tetrahydrocannabinol in a single container.
1679		-	52Article 3 Sec. 2.
1680		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 53.1 (g) (h) An edible cannabinoid product may contain delta-8 tetrahydrocannabinol or
1681		-	53.2delta-9 tetrahydrocannabinol that is extracted from hemp plants or hemp plant parts or is
1682		-	53.3an artificially derived cannabinoid. Edible cannabinoid products are prohibited from
1683		-	53.4containing any other artificially derived cannabinoid, including but not limited to THC-P,
1684		-	53.5THC-O, and HHC, unless the office authorizes use of the artificially derived cannabinoid
1685		-	53.6in edible cannabinoid products. Edible cannabinoid products are prohibited from containing
1686		-	53.7synthetic cannabinoids.
1687		-	53.8 (h) (i) Every person selling edible cannabinoid products to consumers, other than products
1688		-	53.9that are intended to be consumed as a beverage, must ensure that all edible cannabinoid
1689		-	53.10products are displayed behind a checkout counter where the public is not permitted or in a
1690		-	53.11locked case.
1691		-	53.12 EFFECTIVE DATE.This section is effective the day following final enactment.
1692		-	53.13Sec. 3. Minnesota Statutes 2024, section 342.01, subdivision 9, is amended to read:
1693		-	53.14 Subd. 9.Bona fide labor organization."Bona fide labor organization" means a labor
1694		-	53.15union that represents or is actively seeking to represent cannabis workers. of:
1695		-	53.16 (1) a cannabis business; or
1696		-	53.17 (2) a lower-potency hemp edible manufacturer.
1697		-	53.18Sec. 4. Minnesota Statutes 2024, section 342.01, subdivision 34, is amended to read:
1698		-	53.19 Subd. 34.Hemp business.(a) "Hemp business" means either any of the following
1699		-	53.20licensed under this chapter:
1700		-	53.21 (1) lower-potency hemp edible manufacturer; or
1701		-	53.22 (2) lower-potency hemp edible wholesaler; or
1702		-	53.23 (2) (3) lower-potency hemp edible retailer.
1703		-	53.24 (b) Hemp business does not include a person or entity licensed under chapter 18K to
1704		-	53.25grow industrial hemp for commercial or research purposes or to process industrial hemp
1705		-	53.26for commercial purposes.
1706		-	53.27 EFFECTIVE DATE.This section is effective the day following final enactment.
1707		-	53.28Sec. 5. Minnesota Statutes 2024, section 342.01, subdivision 47, is amended to read:
1708		-	53.29 Subd. 47.Labor peace agreement."Labor peace agreement" means an agreement
1709		-	53.30between a cannabis business and a bona fide labor organization or an agreement between
1710		-	53Article 3 Sec. 5.
1711		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 54.1a lower-potency hemp edible manufacturer and a bona fide labor organization that protects
1712		-	54.2the state's interests by, at minimum, prohibiting the labor organization from engaging in
1713		-	54.3picketing, work stoppages, or boycotts against the cannabis business or lower-potency hemp
1714		-	54.4edible manufacturer.
1715		-	54.5 Sec. 6. Minnesota Statutes 2024, section 342.01, subdivision 48, is amended to read:
1716		-	54.6 Subd. 48.License holder."License holder" means a person, cooperative, or business
1717		-	54.7that holds any of the following licenses:
1718		-	54.8 (1) cannabis microbusiness;
1719		-	54.9 (2) cannabis mezzobusiness;
1720		-	54.10 (3) cannabis cultivator;
1721		-	54.11 (4) cannabis manufacturer;
1722		-	54.12 (5) cannabis retailer;
1723		-	54.13 (6) cannabis wholesaler;
1724		-	54.14 (7) cannabis transporter;
1725		-	54.15 (8) cannabis testing facility;
1726		-	54.16 (9) cannabis event organizer;
1727		-	54.17 (10) cannabis delivery service;
1728		-	54.18 (11) lower-potency hemp edible manufacturer;
1729		-	54.19 (12) lower-potency hemp edible wholesaler;
1730		-	54.20 (12) (13) lower-potency hemp edible retailer; or
1731		-	54.21 (13) (14) medical cannabis combination business.
1732		-	54.22 EFFECTIVE DATE.This section is effective the day following final enactment.
1733		-	54.23Sec. 7. Minnesota Statutes 2024, section 342.01, subdivision 50, is amended to read:
1734		-	54.24 Subd. 50.Lower-potency hemp edible.(a) "Lower-potency hemp edible" means any
1735		-	54.25product that:
1736		-	54.26 (1) is intended to be eaten or consumed as a beverage by humans;
1737		-	54.27 (2) contains hemp concentrate or an artificially derived cannabinoid, in combination
1738		-	54.28with food ingredients;
1739		-	54Article 3 Sec. 7.
1740		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 55.1 (3) is not a drug;
1741		-	55.2 (4) does not contain a cannabinoid derived from cannabis plants or cannabis flower;
1742		-	55.3 (5) is a type of product approved for sale by the office or is substantially similar to a
1743		-	55.4product approved by the office, including but not limited to products that resemble
1744		-	55.5nonalcoholic beverages, candy, and baked goods; and
1745		-	55.6 (6) meets either of the requirements in paragraph (b).
1746		-	55.7 (b) A lower-potency hemp edible includes:
1747		-	55.8 (1) a product that:
1748		-	55.9 (i) is not intended to be consumed as a beverage and consists of servings that contain
1749		-	55.10no more than five milligrams of delta-9 tetrahydrocannabinol; is intended to be consumed
1750		-	55.11as a beverage and contains no more than ten milligrams of delta-9 tetrahydrocannabinol in
1751		-	55.12a single container; is intended to be consumed in any approved manner and consists of
1752		-	55.13servings or a container that contain no more than 25 100 milligrams of cannabidiol,
1753		-	55.14cannabigerol, cannabinol, or cannabichromene; is intended to be consumed in any approved
1754		-	55.15manner and contains no more than the established limit of any other cannabinoid authorized
1755		-	55.16by the office; or is intended to be consumed in any approved manner and contains any
1756		-	55.17combination of those cannabinoids that does not exceed the identified amounts for the
1757		-	55.18applicable product category;
1758		-	55.19 (ii) does not contain more than a combined total of 0.5 milligrams of all other
1759		-	55.20cannabinoids per serving; and
1760		-	55.21 (iii) does not contain an artificially derived cannabinoid other than delta-9
1761		-	55.22tetrahydrocannabinol, except that a product may include artificially derived cannabinoids
1762		-	55.23created during the process of creating the delta-9 tetrahydrocannabinol that is added to the
1763		-	55.24product, if no artificially derived cannabinoid is added to the ingredient containing delta-9
1764		-	55.25tetrahydrocannabinol and the ratio of delta-9 tetrahydrocannabinol to all other artificially
1765		-	55.26derived cannabinoids is no less than 20 to one; or
1766		-	55.27 (2) a product that:
1767		-	55.28 (i) contains hemp concentrate processed or refined without increasing the percentage of
1768		-	55.29targeted cannabinoids or altering the ratio of cannabinoids in the extracts or resins of a hemp
1769		-	55.30plant or hemp plant parts beyond the variability generally recognized for the method used
1770		-	55.31for processing or refining or by an amount needed to reduce the total THC in the hemp
1771		-	55.32concentrate; and
1772		-	55Article 3 Sec. 7.
1773		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 56.1 (ii) consists of servings that contain no more than five milligrams of total THC.
1774		-	56.2 EFFECTIVE DATE.This section is effective the day following final enactment.
1775		-	56.3 Sec. 8. Minnesota Statutes 2024, section 342.10, is amended to read:
1776		-	56.4 342.10 LICENSES; TYPES.
1777		-	56.5 The office shall issue the following types of license:
1778		-	56.6 (1) cannabis microbusiness;
1779		-	56.7 (2) cannabis mezzobusiness;
1780		-	56.8 (3) cannabis cultivator;
1781		-	56.9 (4) cannabis manufacturer;
1782		-	56.10 (5) cannabis retailer;
1783		-	56.11 (6) cannabis wholesaler;
1784		-	56.12 (7) cannabis transporter;
1785		-	56.13 (8) cannabis testing facility;
1786		-	56.14 (9) cannabis event organizer;
1787		-	56.15 (10) cannabis delivery service;
1788		-	56.16 (11) lower-potency hemp edible manufacturer;
1789		-	56.17 (12) lower-potency hemp edible wholesaler;
1790		-	56.18 (12) (13) lower-potency hemp edible retailer; and
1791		-	56.19 (13) (14) medical cannabis combination business.
1792		-	56.20 EFFECTIVE DATE.This section is effective the day following final enactment.
1793		-	56.21Sec. 9. Minnesota Statutes 2024, section 342.11, is amended to read:
1794		-	56.22 342.11 LICENSES; FEES.
1795		-	56.23 (a) The office shall require the payment of application fees, initial licensing fees, and
1796		-	56.24renewal licensing fees as provided in this section. The initial license fee shall include the
1797		-	56.25fee for initial issuance of the license and the first annual renewal. The renewal fee shall be
1798		-	56.26charged at the time of the second renewal and each subsequent annual renewal thereafter.
1799		-	56.27Nothing in this section prohibits a local unit of government from charging the retailer
1800		-	56Article 3 Sec. 9.
1801		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 57.1registration fee established in section 342.22. Application fees, initial licensing fees, and
1802		-	57.2renewal licensing fees are nonrefundable.
1803		-	57.3 (b) Application and licensing fees shall be as follows:
1804		-	57.4 (1) for a cannabis microbusiness:
1805		-	57.5 (i) an application fee of $500;
1806		-	57.6 (ii) an initial license fee of $0; and
1807		-	57.7 (iii) a renewal license fee of $2,000;
1808		-	57.8 (2) for a cannabis mezzobusiness:
1809		-	57.9 (i) an application fee of $5,000;
1810		-	57.10 (ii) an initial license fee of $5,000; and
1811		-	57.11 (iii) a renewal license fee of $10,000;
1812		-	57.12 (3) for a cannabis cultivator:
1813		-	57.13 (i) an application fee of $10,000;
1814		-	57.14 (ii) an initial license fee of $20,000; and
1815		-	57.15 (iii) a renewal license fee of $30,000;
1816		-	57.16 (4) for a cannabis manufacturer:
1817		-	57.17 (i) an application fee of $10,000;
1818		-	57.18 (ii) an initial license fee of $10,000; and
1819		-	57.19 (iii) a renewal license fee of $20,000;
1820		-	57.20 (5) for a cannabis retailer:
1821		-	57.21 (i) an application fee of $2,500;
1822		-	57.22 (ii) an initial license fee of $2,500; and
1823		-	57.23 (iii) a renewal license fee of $5,000;
1824		-	57.24 (6) for a cannabis wholesaler:
1825		-	57.25 (i) an application fee of $5,000;
1826		-	57.26 (ii) an initial license fee of $5,000; and
1827		-	57.27 (iii) a renewal license fee of $10,000;
1828		-	57Article 3 Sec. 9.
1829		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 58.1 (7) for a cannabis transporter:
1830		-	58.2 (i) an application fee of $250;
1831		-	58.3 (ii) an initial license fee of $500; and
1832		-	58.4 (iii) a renewal license fee of $1,000;
1833		-	58.5 (8) for a cannabis testing facility:
1834		-	58.6 (i) an application fee of $5,000;
1835		-	58.7 (ii) an initial license fee of $5,000; and
1836		-	58.8 (iii) a renewal license fee of $10,000;
1837		-	58.9 (9) for a cannabis delivery service:
1838		-	58.10 (i) an application fee of $250;
1839		-	58.11 (ii) an initial license fee of $500; and
1840		-	58.12 (iii) a renewal license fee of $1,000;
1841		-	58.13 (10) for a cannabis event organizer:
1842		-	58.14 (i) an application fee of $750; and
1843		-	58.15 (ii) an initial license fee of $750;
1844		-	58.16 (11) for a lower-potency hemp edible manufacturer:
1845		-	58.17 (i) an application fee of $250;
1846		-	58.18 (ii) an initial license fee of $1,000; and
1847		-	58.19 (iii) a renewal license fee of $1,000;
1848		-	58.20 (12) for a lower-potency hemp edible wholesaler:
1849		-	58.21 (i) an application fee of $250;
1850		-	58.22 (ii) an initial license fee of $10,000; and
1851		-	58.23 (iii) a renewal license fee of $10,000;
1852		-	58.24 (12) (13) for a lower-potency hemp edible retailer:
1853		-	58.25 (i) an application fee of $250 or, if the lower-potency hemp retailer operates more than
1854		-	58.26one retail location, $250 per retail location;
1855		-	58.27 (ii) an initial license fee of $250 or, if the lower-potency hemp retailer operates more
1856		-	58.28than one retail location, $250 per retail location; and
1857		-	58Article 3 Sec. 9.
1858		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 59.1 (iii) a renewal license fee of $250 or, if the lower-potency hemp retailer operates more
1859		-	59.2than one retail location, $250 per retail location; and
1860		-	59.3 (13) (14) for a medical cannabis combination business:
1861		-	59.4 (i) an application fee of $10,000;
1862		-	59.5 (ii) an initial license fee of $20,000; and
1863		-	59.6 (iii) a renewal license fee of $70,000.
1864		-	59.7 EFFECTIVE DATE.This section is effective the day following final enactment.
1865		-	59.8 Sec. 10. Minnesota Statutes 2024, section 342.13, is amended to read:
1866		-	59.9 342.13 LOCAL CONTROL.
1867		-	59.10 (a) A local unit of government may not prohibit the possession, transportation, or use
1868		-	59.11of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived
1869		-	59.12consumer products authorized under this chapter.
1870		-	59.13 (b) Except as provided in section 342.22, a local unit of government may not prohibit
1871		-	59.14the establishment or operation of a cannabis business or hemp business licensed under this
1872		-	59.15chapter.
1873		-	59.16 (c) A local unit of government may adopt reasonable restrictions on the time, place, and
1874		-	59.17manner of the operation of a cannabis business provided that such restrictions do not prohibit
1875		-	59.18the establishment or operation of cannabis businesses. A local unit of government may
1876		-	59.19prohibit the operation of a cannabis business within 1,000 feet of a school, or 500 feet of a
1877		-	59.20day care, residential treatment facility, or an attraction within a public park that is regularly
1878		-	59.21used by minors, including a playground or athletic field.
1879		-	59.22 (d) The office shall work with local units of government to:
1880		-	59.23 (1) develop model ordinances for reasonable restrictions on the time, place, and manner
1881		-	59.24of the operation of a cannabis business;
1882		-	59.25 (2) develop standardized forms and procedures for the issuance of a retail registration
1883		-	59.26pursuant to section 342.22; and
1884		-	59.27 (3) develop model policies and procedures for the performance of compliance checks
1885		-	59.28required under section 342.22.
1886		-	59.29 (e) If a local unit of government is conducting studies or has authorized a study to be
1887		-	59.30conducted or has held or has scheduled a hearing for the purpose of considering adoption
1888		-	59.31or amendment of reasonable restrictions on the time, place, and manner of the operation of
1889		-	59Article 3 Sec. 10.
1890		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 60.1a cannabis business, the governing body of the local unit of government may adopt an
1891		-	60.2interim ordinance applicable to all or part of its jurisdiction for the purpose of protecting
1892		-	60.3the planning process and the health, safety, and welfare of its citizens. Before adopting the
1893		-	60.4interim ordinance, the governing body must hold a public hearing. The interim ordinance
1894		-	60.5may regulate, restrict, or prohibit the operation of a cannabis business within the jurisdiction
1895		-	60.6or a portion thereof until January 1, 2025.
1896		-	60.7 (f) Within 30 days of receiving a copy of an application from the office, a local unit of
1897		-	60.8government shall certify on a form provided by the office whether a proposed cannabis
1898		-	60.9business complies with local zoning ordinances and, if applicable, whether the proposed
1899		-	60.10business complies with the state fire code and building code. The office may not issue a
1900		-	60.11license if the local unit of government informs the office that the cannabis business does
1901		-	60.12not meet local zoning and land use laws. If the local unit of government does not provide
1902		-	60.13the certification to the office within 30 days of receiving a copy of an application from the
1903		-	60.14office, the office may issue a license.
1904		-	60.15 (g) The office by rule shall establish an expedited complaint process to receive, review,
1905		-	60.16and respond to complaints made by a local unit of government about a cannabis business.
1906		-	60.17At a minimum, the expedited complaint process shall require the office to provide an initial
1907		-	60.18response to the complaint within seven days and perform any necessary inspections within
1908		-	60.1930 days. Nothing in this paragraph prohibits a local unit of government from enforcing a
1909		-	60.20local ordinance. If a local unit of government notifies the office that a cannabis business
1910		-	60.21other than a cannabis retailer, cannabis microbusiness or, cannabis mezzobusiness or
1911		-	60.22lower-potency hemp edible retailer with a retail operations endorsement, lower-potency
1912		-	60.23hemp edible retailer, or medical cannabis combination business operating a retail location
1913		-	60.24poses an immediate threat to the health or safety of the public, the office must respond
1914		-	60.25within one business day and may take any action described in section 342.19 or 342.21.
1915		-	60.26 (h) A local government unit that issues a cannabis retailer registration under section
1916		-	60.27342.22 may, by ordinance, limit the number of licensed cannabis retailers, cannabis
1917		-	60.28mezzobusinesses with a retail operations endorsement, and cannabis microbusinesses with
1918		-	60.29a retail operations endorsement to no fewer than one registration for every 12,500 residents.
1919		-	60.30 (i) If a county has one active registration for every 12,500 residents, a city or town within
1920		-	60.31the county is not obligated to register a cannabis business.
1921		-	60.32 (j) Nothing in this section shall prohibit a local government unit from allowing licensed
1922		-	60.33cannabis retailers in excess of the minimums set in paragraph (h).
1923		-	60Article 3 Sec. 10.
1924		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 61.1 (k) Notwithstanding the foregoing provisions, the state shall not issue a license to any
1925		-	61.2cannabis business to operate in Indian country, as defined in United States Code, title 18,
1926		-	61.3section 1151, of a Minnesota Tribal government without the consent of the Tribal
1927		-	61.4government.
1928		-	61.5 EFFECTIVE DATE.This section is effective the day following final enactment.
1929		-	61.6 Sec. 11. Minnesota Statutes 2024, section 342.18, subdivision 2, is amended to read:
1930		-	61.7 Subd. 2.Vertical integration prohibited; exceptions.(a) Except as otherwise provided
1931		-	61.8in this subdivision, the office shall not issue licenses to a single applicant that would result
1932		-	61.9in the applicant being vertically integrated in violation of the provisions of this chapter.
1933		-	61.10 (b) Nothing in this section prohibits or limits the issuance of microbusiness licenses,
1934		-	61.11mezzobusiness licenses, or medical cannabis combination business licenses, or the issuance
1935		-	61.12of both lower-potency hemp edible manufacturer, lower-potency hemp edible wholesaler,
1936		-	61.13and lower-potency hemp edible retailer licenses to the same person or entity.
1937		-	61.14 EFFECTIVE DATE.This section is effective the day following final enactment.
1938		-	61.15Sec. 12. Minnesota Statutes 2024, section 342.22, is amended by adding a subdivision to
1939		-	61.16read:
1940		-	61.17 Subd. 6.Exception; exclusive delivery services.The requirements of this section do
1941		-	61.18not apply to a lower-potency hemp edible retailer with a delivery endorsement if the
1942		-	61.19lower-potency hemp edible retailer does not operate a retail location.
1943		-	61.20 EFFECTIVE DATE.This section is effective the day following final enactment.
1944		-	61.21Sec. 13. Minnesota Statutes 2024, section 342.34, subdivision 5, is amended to read:
1945		-	61.22 Subd. 5.Importation of hemp-derived products.(a) A cannabis wholesaler that imports
1946		-	61.23lower-potency hemp edibles or hemp-derived consumer products, other than hemp-derived
1947		-	61.24topical products, that are manufactured outside the boundaries of the state of Minnesota
1948		-	61.25with the intent to sell the products to a cannabis microbusiness, cannabis mezzobusiness,
1949		-	61.26cannabis retailer, lower-potency hemp edible wholesaler, or lower-potency hemp edible
1950		-	61.27retailer must obtain a hemp-derived product importer endorsement from the office.
1951		-	61.28 (b) A cannabis wholesaler with a hemp-derived product importer endorsement may sell
1952		-	61.29products manufactured outside the boundaries of the state of Minnesota if:
1953		-	61Article 3 Sec. 13.
1954		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 62.1 (1) the manufacturer is licensed in another jurisdiction and subject to regulations designed
1955		-	62.2to protect the health and safety of consumers that the office determines are substantially
1956		-	62.3similar to the regulations in this state; or
1957		-	62.4 (2) the cannabis wholesaler establishes, to the satisfaction of the office, that the
1958		-	62.5manufacturer engages in practices that are substantially similar to the practices required for
1959		-	62.6licensure of manufacturers in this state.
1960		-	62.7 (c) The cannabis wholesaler must enter all relevant information regarding an imported
1961		-	62.8hemp-derived consumer product into the statewide monitoring system before the product
1962		-	62.9may be distributed. Relevant information includes information regarding the cultivation,
1963		-	62.10processing, and testing of the industrial hemp used in the manufacture of the product and
1964		-	62.11information regarding the testing of the hemp-derived consumer product. If information
1965		-	62.12regarding the industrial hemp or hemp-derived consumer product was submitted to a
1966		-	62.13statewide monitoring system used in another state, the office may require submission of
1967		-	62.14any information provided to that statewide monitoring system and shall assist in the transfer
1968		-	62.15of data from another state as needed and in compliance with any data classification
1969		-	62.16established by either state.
1970		-	62.17 (d) The office may suspend, revoke, or cancel the endorsement of a distributor who is
1971		-	62.18prohibited from distributing products containing cannabinoids in any other jurisdiction,
1972		-	62.19convicted of an offense involving the distribution of products containing cannabinoids in
1973		-	62.20any other jurisdiction, or found liable for distributing any product that injured customers in
1974		-	62.21any other jurisdiction. A cannabis wholesaler shall disclose all relevant information related
1975		-	62.22to actions in another jurisdiction. Failure to disclose relevant information may result in
1976		-	62.23disciplinary action by the office, including the suspension, revocation, or cancellation of
1977		-	62.24an endorsement or license.
1978		-	62.25 (e) Notwithstanding any law to the contrary, it shall not be a defense in any civil or
1979		-	62.26criminal action that a licensed wholesaler relied on information on a product label or
1980		-	62.27otherwise provided by a manufacturer who is not licensed in this state.
1981		-	62.28 EFFECTIVE DATE.This section is effective the day following final enactment.
1982		-	62.29Sec. 14. Minnesota Statutes 2024, section 342.39, subdivision 3, is amended to read:
1983		-	62.30 Subd. 3.Multiple licenses; limits.(a) A person, cooperative, or business holding a
1984		-	62.31cannabis event organizer license may not hold a cannabis testing facility license, a
1985		-	62.32lower-potency hemp edible manufacturer license, a lower-potency hemp edible wholesaler
1986		-	62.33license, or a lower-potency hemp edible retailer license.
1987		-	62Article 3 Sec. 14.
1988		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 63.1 (b) The office by rule may limit the number of cannabis event licenses that a person or
1989		-	63.2business may hold.
1990		-	63.3 (c) For purposes of this subdivision, restrictions on the number or type of license that a
1991		-	63.4business may hold apply to every cooperative member or every director, manager, and
1992		-	63.5general partner of a cannabis business.
1993		-	63.6 EFFECTIVE DATE.This section is effective the day following final enactment.
1994		-	63.7 Sec. 15. Minnesota Statutes 2024, section 342.43, subdivision 1, is amended to read:
1995		-	63.8 Subdivision 1.License types.The office shall issue the following types of hemp business
1996		-	63.9licenses:
1997		-	63.10 (1) lower-potency hemp edible manufacturer; and
1998		-	63.11 (2) lower-potency hemp edible wholesaler; and
1999		-	63.12 (2) (3) lower-potency hemp edible retailer.
2000		-	63.13 EFFECTIVE DATE.This section is effective the day following final enactment.
2001		-	63.14Sec. 16. Minnesota Statutes 2024, section 342.43, subdivision 2, is amended to read:
2002		-	63.15 Subd. 2.Multiple licenses; limits.(a) A person, cooperative, or business may hold both
2003		-	63.16any combination of a lower-potency hemp edible manufacturer, a lower-potency hemp
2004		-	63.17edible wholesaler, and a lower-potency hemp edible retailer license.
2005		-	63.18 (b) Nothing in this section prohibits a person, cooperative, or business from holding a
2006		-	63.19lower-potency hemp edible manufacturer license, a lower-potency hemp edible wholesaler
2007		-	63.20license, a lower-potency hemp edible retailer license, or both any combination of those
2008		-	63.21licenses, and also holding a license to cultivate industrial hemp issued pursuant to chapter
2009		-	63.2218K.
2010		-	63.23 (c) Nothing in this section prohibits a person, cooperative, or business from holding a
2011		-	63.24lower-potency hemp edible manufacturer license, a lower-potency hemp edible wholesaler
2012		-	63.25license, a lower-potency hemp edible retailer license, or both any combination of those
2013		-	63.26licenses, and also holding any other license, including but not limited to a license to prepare
2014		-	63.27or sell food; sell tobacco, tobacco-related devices, electronic delivery devices as defined in
2015		-	63.28section 609.685, subdivision 1, and nicotine and lobelia delivery products as described in
2016		-	63.29section 609.6855; or manufacture or sell alcoholic beverages as defined in section 340A.101,
2017		-	63.30subdivision 2.
2018		-	63Article 3 Sec. 16.
2019		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 64.1 (d) A person, cooperative, or business holding a lower-potency hemp edible manufacturer
2020		-	64.2license, a lower-potency hemp edible wholesaler license, a lower-potency hemp edible
2021		-	64.3retailer license, or both any combination of those licenses, may not hold a cannabis business
2022		-	64.4license.
2023		-	64.5 EFFECTIVE DATE.This section is effective the day following final enactment.
2024		-	64.6 Sec. 17. Minnesota Statutes 2024, section 342.44, subdivision 1, is amended to read:
2025		-	64.7 Subdivision 1.Application; contents.(a) Except as otherwise provided in this
2026		-	64.8subdivision, the provisions of this chapter relating to license applications, license selection
2027		-	64.9criteria, general ownership disqualifications and requirements, and general operational
2028		-	64.10requirements do not apply to hemp businesses.
2029		-	64.11 (b) The office, by rule, shall establish forms and procedures for the processing of hemp
2030		-	64.12licenses issued under this chapter. At a minimum, any application to obtain or renew a hemp
2031		-	64.13license shall include the following information, if applicable:
2032		-	64.14 (1) the name, address, and date of birth of the applicant;
2033		-	64.15 (2) the address and legal property description of the business;
2034		-	64.16 (3) proof of trade name registration;
2035		-	64.17 (4) certification that the applicant will comply with the requirements of this chapter
2036		-	64.18relating to the ownership and operation of a hemp business;
2037		-	64.19 (5) identification of one or more controlling persons or managerial employees as agents
2038		-	64.20who shall be responsible for dealing with the office on all matters; and
2039		-	64.21 (6) a statement that the applicant agrees to respond to the office's supplemental requests
2040		-	64.22for information.
2041		-	64.23 (c) An applicant for a lower-potency hemp edible manufacturer license must submit an
2042		-	64.24attestation signed by a bona fide labor organization stating that the applicant has entered
2043		-	64.25into a labor peace agreement.
2044		-	64.26 (d) An application on behalf of a corporation or association shall be signed by at least
2045		-	64.27two officers or managing agents of that entity.
2046		-	64.28 EFFECTIVE DATE.This section is effective the day following final enactment.
2047		-	64Article 3 Sec. 17.
2048		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 65.1 Sec. 18. Minnesota Statutes 2024, section 342.45, is amended by adding a subdivision to
2049		-	65.2read:
2050		-	65.3 Subd. 6.Building conditions.(a) A lower-potency hemp edible manufacturer must
2051		-	65.4comply with state and local building, fire, and zoning codes, requirements, and regulations.
2052		-	65.5 (b) A lower-potency hemp edible manufacturer must ensure that licensed premises are
2053		-	65.6maintained in a clean and sanitary condition and are free from infestation by insects, rodents,
2054		-	65.7or other pests.
2055		-	65.8 Sec. 19. Minnesota Statutes 2024, section 342.45, is amended by adding a subdivision to
2056		-	65.9read:
2057		-	65.10 Subd. 7.Manufacture of products for sale in other jurisdictions.(a) Nothing in this
2058		-	65.11chapter prohibits a lower-potency hemp edible manufacturer from manufacturing, packaging,
2059		-	65.12labeling, and distributing edible products containing cannabinoids derived from hemp that
2060		-	65.13do not qualify as lower-potency hemp edibles if:
2061		-	65.14 (1) the products are intended, distributed, and offered for sale only in jurisdictions other
2062		-	65.15than Minnesota;
2063		-	65.16 (2) the products are physically separated from all lower-potency hemp edibles during
2064		-	65.17the manufacturing, packaging, and labeling process; and
2065		-	65.18 (3) the products' packaging clearly states that the products are not for sale in Minnesota.
2066		-	65.19 (b) The office may take enforcement action as provided in sections 342.19 and 342.21
2067		-	65.20if the office determines that the lower-potency hemp edible manufacturer:
2068		-	65.21 (1) sold or offered for sale in Minnesota any edible product containing cannabinoids
2069		-	65.22derived from hemp that does not qualify as a lower-potency hemp edible; or
2070		-	65.23 (2) manufactured, distributed, or stored any edible product containing cannabinoids
2071		-	65.24derived from hemp that does not qualify as a lower-potency hemp edible with the intent
2072		-	65.25that the product be offered for sale in Minnesota.
2073		-	65.26Sec. 20. [342.455] LOWER-POTENCY HEMP EDIBLE WHOLESALER.
2074		-	65.27 Subdivision 1.Authorized actions.A lower-potency hemp edible wholesaler license,
2075		-	65.28consistent with the specific license endorsement or endorsements, entitles the license holder
2076		-	65.29to perform any or all of the following within the limits established by this section:
2077		-	65Article 3 Sec. 20.
2078		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 66.1 (1) purchase lower-potency hemp edibles from cannabis microbusinesses, cannabis
2079		-	66.2mezzobusinesses, cannabis cultivators, cannabis manufacturers, cannabis wholesalers, other
2080		-	66.3lower-potency hemp edible wholesalers, and lower-potency hemp edible manufacturers;
2081		-	66.4 (2) sell lower-potency hemp edibles to lower-potency hemp edible retailers with a retail
2082		-	66.5endorsement, cannabis microbusinesses with a retail endorsement, cannabis mezzobusinesses
2083		-	66.6with a retail endorsement, cannabis retailers, cannabis wholesalers, medical cannabis
2084		-	66.7combination businesses, and other lower-potency hemp edible wholesalers;
2085		-	66.8 (3) import lower-potency hemp edibles that contain hemp concentrate or artificially
2086		-	66.9derived cannabinoids that are derived from hemp plants or hemp plant parts; and
2087		-	66.10 (4) perform other actions approved by the office.
2088		-	66.11 Subd. 2.Operations.(a) A lower-potency hemp edible wholesaler must maintain accurate
2089		-	66.12records and ensure that appropriate labels remain affixed to lower-potency hemp edibles.
2090		-	66.13 (b) A lower-potency hemp edible wholesaler must maintain compliance with state and
2091		-	66.14local building, fire, and zoning requirements or regulations and must ensure that the
2092		-	66.15wholesaler's premises are maintained in a clean and sanitary condition, free from infestation
2093		-	66.16by insects, rodents, or other pests.
2094		-	66.17 (c) A lower-potency hemp edible wholesaler may purchase and sell other products or
2095		-	66.18items for which the wholesaler has a license or an authorization or that do not require a
2096		-	66.19license or an authorization. Products for which no license or authorization is required include
2097		-	66.20but are not limited to industrial hemp products, products that contain hemp grain,
2098		-	66.21hemp-derived topical products, and cannabis paraphernalia. Cannabis paraphernalia includes
2099		-	66.22but is not limited to childproof packaging containers and other devices designed to ensure
2100		-	66.23the safe storage and monitoring of cannabis flower and cannabis products in the home to
2101		-	66.24prevent access by individuals under 21 years of age.
2102		-	66.25 Subd. 3.Importation of lower-potency hemp edibles; endorsement.(a) A
2103		-	66.26lower-potency hemp edible wholesaler that imports lower-potency hemp edibles that are
2104		-	66.27manufactured outside the boundaries of the state of Minnesota with the intent to sell the
2105		-	66.28products to a cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, cannabis
2106		-	66.29wholesaler, medical cannabis combination business, other lower-potency hemp edible
2107		-	66.30wholesaler, or lower-potency hemp edible retailer must obtain a lower-potency hemp edible
2108		-	66.31importer endorsement from the office.
2109		-	66Article 3 Sec. 20.
2110		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 67.1 (b) A lower-potency hemp edible wholesaler with an endorsement issued under this
2111		-	67.2subdivision may sell products manufactured outside the boundaries of the state of Minnesota
2112		-	67.3if:
2113		-	67.4 (1) the manufacturer is licensed in another jurisdiction and subject to regulations designed
2114		-	67.5to protect the health and safety of consumers that the office determines are substantially
2115		-	67.6similar to the regulations in this state; or
2116		-	67.7 (2) the lower-potency hemp edible wholesaler establishes, to the satisfaction of the office,
2117		-	67.8that the manufacturer engages in practices that are substantially similar to the practices
2118		-	67.9required for licensure of manufacturers in this state.
2119		-	67.10 (c) The office may suspend, revoke, or cancel the license or endorsement of a wholesaler
2120		-	67.11who is prohibited from distributing products containing cannabinoids in any other jurisdiction,
2121		-	67.12convicted of an offense involving the distribution of products containing cannabinoids in
2122		-	67.13any other jurisdiction, or found liable for distributing any product that injured customers in
2123		-	67.14any other jurisdiction. A lower-potency hemp edible wholesaler shall disclose all relevant
2124		-	67.15information related to actions in another jurisdiction. Failure to disclose relevant information
2125		-	67.16may result in disciplinary action by the office, including the suspension, revocation, or
2126		-	67.17cancellation of an endorsement or license.
2127		-	67.18 (d) Notwithstanding any law to the contrary, it is not a defense in any civil or criminal
2128		-	67.19action that a wholesaler relied on information on a product label or otherwise provided by
2129		-	67.20a manufacturer who is not licensed in this state.
2130		-	67.21 Subd. 4.Transportation of lower-potency hemp edibles; endorsement.(a) A
2131		-	67.22lower-potency hemp edible wholesaler that transports lower-potency hemp edibles to a
2132		-	67.23cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, cannabis wholesaler,
2133		-	67.24medical cannabis combination business, different lower-potency hemp edible wholesaler,
2134		-	67.25or lower-potency hemp edible retailer must obtain a lower-potency hemp edible transporter
2135		-	67.26endorsement from the office.
2136		-	67.27 (b) In addition to the information required to be submitted under section 342.44,
2137		-	67.28subdivision 1, and rules adopted pursuant to that section, a person, cooperative, or business
2138		-	67.29seeking a lower-potency hemp edible transporter endorsement must submit the following
2139		-	67.30information in a form approved by the office:
2140		-	67.31 (1) an appropriate surety bond, a certificate of insurance, qualifications as a self-insurer,
2141		-	67.32or other securities or agreements, in the amount of not less than $300,000, for loss of or
2142		-	67.33damage to cargo;
2143		-	67Article 3 Sec. 20.
2144		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 68.1 (2) an appropriate surety bond, a certificate of insurance, qualifications as a self-insurer,
2145		-	68.2or other securities or agreements, in the amount of not less than $1,000,000, for injury to
2146		-	68.3one or more persons in any one accident and, if an accident has resulted in injury to or
2147		-	68.4destruction of property, of not less than $100,000 because of such injury to or destruction
2148		-	68.5of property of others in any one accident;
2149		-	68.6 (3) the number and type of equipment the business will use to transport lower-potency
2150		-	68.7hemp edibles;
2151		-	68.8 (4) a loading, transporting, and unloading plan;
2152		-	68.9 (5) a description of the applicant's experience in the distribution or security business;
2153		-	68.10and
2154		-	68.11 (6) evidence that the business will comply with the applicable operation requirements
2155		-	68.12for the license being sought.
2156		-	68.13 (c) A lower-potency hemp edible wholesaler may transport lower-potency hemp edibles
2157		-	68.14on public roadways if:
2158		-	68.15 (1) the lower-potency hemp edibles are in a locked, safe, and secure storage compartment
2159		-	68.16that is part of the motor vehicle or in a locked storage container that has a separate key or
2160		-	68.17combination pad;
2161		-	68.18 (2) the lower-potency hemp edibles are packaged in tamper-evident containers that are
2162		-	68.19not visible or recognizable from outside the transporting vehicle;
2163		-	68.20 (3) the lower-potency hemp edible wholesaler has a shipping manifest in the wholesaler's
2164		-	68.21possession that describes the contents of all tamper-evident containers;
2165		-	68.22 (4) all departures, arrivals, and stops are appropriately documented;
2166		-	68.23 (5) no person other than a designated employee enters a vehicle at any time that the
2167		-	68.24vehicle is transporting lower-potency hemp edibles;
2168		-	68.25 (6) at all times that the vehicle contains lower-potency hemp edibles, the vehicle is (i)
2169		-	68.26secured by turning off the ignition, locking all doors and storage compartments, and removing
2170		-	68.27the operating keys or device, or (ii) attended by a lower-potency hemp edible wholesaler
2171		-	68.28employee; and
2172		-	68.29 (7) the lower-potency hemp edible wholesaler complies with any other rules adopted
2173		-	68.30by the office related to the transportation of lower-potency hemp edibles by a lower-potency
2174		-	68.31hemp edible wholesaler, except that rules requiring a lower-potency hemp edible wholesaler
2175		-	68Article 3 Sec. 20.
2176		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 69.1to randomize delivery times and routes or staff vehicles with multiple employees do not
2177		-	69.2apply.
2178		-	69.3 (d) Any vehicle assigned for the purposes of transporting lower-potency hemp edibles
2179		-	69.4is subject to inspection at any time.
2180		-	69.5 EFFECTIVE DATE.This section is effective the day following final enactment.
2181		-	69.6 Sec. 21. Minnesota Statutes 2024, section 342.46, subdivision 1, is amended to read:
2182		-	69.7 Subdivision 1.Sale of lower-potency hemp edibles Authorized actions.(a) A
2183		-	69.8lower-potency hemp edible retailer may only sell lower-potency hemp edibles to individuals
2184		-	69.9who are at least 21 years of age. license, consistent with the specific license endorsement
2185		-	69.10or endorsements, entitles the license holder to perform any or all of the following within
2186		-	69.11the limits established by this section:
2187		-	69.12 (b) A lower-potency hemp edible retailer may sell lower-potency hemp edibles that:
2188		-	69.13 (1) are obtained purchase lower-potency hemp edibles from a licensed Minnesota cannabis
2189		-	69.14microbusiness, cannabis mezzobusiness, cannabis manufacturer, cannabis wholesaler, or
2190		-	69.15lower-potency hemp edible manufacturer, or lower-potency hemp edible wholesaler; and
2191		-	69.16 (2) meet all applicable packaging and labeling requirements sell lower-potency hemp
2192		-	69.17edibles that meet all packaging and labeling requirements to customers who are at least 21
2193		-	69.18years of age;
2194		-	69.19 (3) transport and deliver lower-potency hemp edibles to customers; and
2195		-	69.20 (4) perform other actions approved by the office.
2196		-	69.21 EFFECTIVE DATE.This section is effective the day following final enactment.
2197		-	69.22Sec. 22. Minnesota Statutes 2024, section 342.46, is amended by adding a subdivision to
2198		-	69.23read:
2199		-	69.24 Subd. 1a.Retailer operations endorsement.In addition to the information required to
2200		-	69.25be submitted under section 342.44, subdivision 1, a lower-potency hemp edible retailer that
2201		-	69.26intends to operate a retail establishment must indicate that intent in the form and manner
2202		-	69.27approved by the office.
2203		-	69.28 EFFECTIVE DATE.This section is effective the day following final enactment.
2204		-	69Article 3 Sec. 22.
2205		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 70.1 Sec. 23. Minnesota Statutes 2024, section 342.46, is amended by adding a subdivision to
2206		-	70.2read:
2207		-	70.3 Subd. 1b.Delivery endorsement.(a) In addition to the information required to be
2208		-	70.4submitted under section 342.44, subdivision 1, a lower-potency hemp edible retailer that
2209		-	70.5delivers lower-potency hemp edibles must submit the following information in a form
2210		-	70.6approved by the office:
2211		-	70.7 (1) proof of insurance for each vehicle;
2212		-	70.8 (2) a business plan demonstrating policies to avoid sales of lower-potency hemp edibles
2213		-	70.9to individuals who are under 21 years of age; and
2214		-	70.10 (3) evidence that the business will comply with the applicable operation requirements
2215		-	70.11for the license being sought.
2216		-	70.12 (b) A lower-potency hemp edible retailer with a delivery endorsement:
2217		-	70.13 (1) must ensure that lower-potency hemp edibles are not visible from outside the delivery
2218		-	70.14vehicle;
2219		-	70.15 (2) must ensure that a vehicle that contains lower-potency hemp edibles is (i) secured
2220		-	70.16by turning off the ignition, locking all doors and storage compartments, and removing the
2221		-	70.17operating keys or device, or (ii) attended by a lower-potency hemp edible retailer employee;
2222		-	70.18and
2223		-	70.19 (3) must not use a vehicle or trailer with an image depicting the types of items being
2224		-	70.20transported, including but not limited to an image depicting a cannabis or hemp leaf, or a
2225		-	70.21name suggesting that the delivery vehicle is used for transporting lower-potency hemp
2226		-	70.22edibles.
2227		-	70.23 (c) Any vehicle delivering lower-potency hemp edibles is subject to inspection at any
2228		-	70.24time.
2229		-	70.25 (d) The office may, by policy, establish limits on the amount of lower-potency hemp
2230		-	70.26edibles that a single delivery vehicle may transport at any time. If the office establishes
2231		-	70.27limits under this paragraph, the office must notify all lower-potency hemp edible retailers
2232		-	70.28with a delivery endorsement of the limit and must post the limit on the office's publicly
2233		-	70.29accessible website.
2234		-	70.30 EFFECTIVE DATE.This section is effective the day following final enactment.
2235		-	70Article 3 Sec. 23.
2236		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 71.1 Sec. 24. Minnesota Statutes 2024, section 342.46, subdivision 3, is amended to read:
2237		-	71.2 Subd. 3.Age verification.Prior to initiating a sale or completing a delivery, an employee
2238		-	71.3of the lower-potency hemp edible retailer must verify that the customer is at least 21 years
2239		-	71.4of age. Section 342.27, subdivision 4, applies to the verification of a customer's age.
2240		-	71.5 EFFECTIVE DATE.This section is effective the day following final enactment.
2241		-	71.6 Sec. 25. Minnesota Statutes 2024, section 342.46, subdivision 4, is amended to read:
2242		-	71.7 Subd. 4.Display and storage of lower-potency hemp edibles.A lower-potency hemp
2243		-	71.8edible retailer operating a retail location shall ensure that all lower-potency hemp edibles,
2244		-	71.9other than lower-potency hemp edibles that are intended to be consumed as a beverage, are
2245		-	71.10displayed behind a checkout counter where the public is not permitted or in a locked case.
2246		-	71.11All lower-potency hemp edibles that are not displayed must be stored in a secure area.
2247		-	71.12 EFFECTIVE DATE.This section is effective the day following final enactment.
2248		-	71.13Sec. 26. Minnesota Statutes 2024, section 342.46, subdivision 5, is amended to read:
2249		-	71.14 Subd. 5.Transportation of lower-potency hemp edibles.(a) A lower-potency hemp
2250		-	71.15edible retailer may transport lower-potency hemp edibles on public roadways provided:
2251		-	71.16 (1) the lower-potency hemp edibles are in final packaging;
2252		-	71.17 (2) the lower-potency hemp edibles are packaged in tamper-evident containers that are
2253		-	71.18not visible or recognizable from outside the transporting vehicle;
2254		-	71.19 (3) the lower-potency hemp edible retailer has a shipping manifest in the lower-potency
2255		-	71.20hemp edible retailer's possession that describes the contents of all tamper-evident containers;
2256		-	71.21 (4) all departures, arrivals, and stops are appropriately documented;
2257		-	71.22 (5) no person other than a designated employee enters a vehicle at any time that the
2258		-	71.23vehicle is transporting lower-potency hemp edibles; and
2259		-	71.24 (6) the lower-potency hemp edible retailer complies with any other rules adopted by the
2260		-	71.25office, except that rules requiring a lower-potency hemp edible retailer to randomize delivery
2261		-	71.26times and routes or staff vehicles with multiple employees do not apply.
2262		-	71.27 (b) Any vehicle assigned for the purposes of transporting lower-potency hemp edibles
2263		-	71.28is subject to inspection at any time.
2264		-	71Article 3 Sec. 26.
2265		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 72.1 (c) The requirements under paragraph (a) do not apply to the delivery of lower-potency
2266		-	72.2hemp edibles to customers by a lower-potency hemp edible retailer with a delivery
2267		-	72.3endorsement.
2268		-	72.4 EFFECTIVE DATE.This section is effective the day following final enactment.
2269		-	72.5 Sec. 27. Minnesota Statutes 2024, section 342.46, subdivision 6, is amended to read:
2270		-	72.6 Subd. 6.Compliant products.(a) A lower-potency hemp edible retailer shall ensure
2271		-	72.7that all lower-potency hemp edibles products containing cannabinoids offered for sale
2272		-	72.8qualify as hemp-derived topical products or lower-potency hemp edibles and comply with
2273		-	72.9the all applicable limits on the amount and types of cannabinoids that a lower-potency hemp
2274		-	72.10edible the product can contain, including but not limited to the requirement that lower-potency
2275		-	72.11hemp edibles:.
2276		-	72.12 (1) consist of servings that contain no more than five milligrams of delta-9
2277		-	72.13tetrahydrocannabinol, no more than 25 milligrams of cannabidiol, no more than 25 milligrams
2278		-	72.14of cannabigerol, or any combination of those cannabinoids that does not exceed the identified
2279		-	72.15amounts;
2280		-	72.16 (2) do not contain more than a combined total of 0.5 milligrams of all other cannabinoids
2281		-	72.17per serving; and
2282		-	72.18 (3) do not contain an artificially derived cannabinoid other than delta-9
2283		-	72.19tetrahydrocannabinol.
2284		-	72.20 (b) If a lower-potency hemp edible is packaged in a manner that includes more than a
2285		-	72.21single serving, the lower-potency hemp edible must indicate each serving by scoring,
2286		-	72.22wrapping, or other indicators that appear on the lower-potency hemp edible designating the
2287		-	72.23individual serving size. If it is not possible to indicate a single serving by scoring or use of
2288		-	72.24another indicator that appears on the product, the lower-potency hemp edible may not be
2289		-	72.25packaged in a manner that includes more than a single serving in each container, except
2290		-	72.26that a calibrated dropper, measuring spoon, or similar device for measuring a single serving
2291		-	72.27may be used for any edible cannabinoid products that are intended to be combined with
2292		-	72.28food or beverage products prior to consumption. If the lower-potency hemp edible is meant
2293		-	72.29to be consumed as a beverage, the beverage container may not contain more than two
2294		-	72.30servings per container.
2295		-	72.31 (c) A single package containing multiple servings of a lower-potency hemp edible must
2296		-	72.32contain no more than 50 milligrams of delta-9 tetrahydrocannabinol, 250 milligrams of
2297		-	72Article 3 Sec. 27.
2298		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 73.1cannabidiol, 250 milligrams of cannabigerol, or any combination of those cannabinoids that
2299		-	73.2does not exceed the identified amounts.
2300		-	73.3 EFFECTIVE DATE.This section is effective the day following final enactment.
2301		-	73.4 Sec. 28. Minnesota Statutes 2024, section 342.46, subdivision 7, is amended to read:
2302		-	73.5 Subd. 7.Prohibitions.A lower-potency hemp edible retailer may must not:
2303		-	73.6 (1) sell or deliver lower-potency hemp edibles to an individual who is under 21 years
2304		-	73.7of age;
2305		-	73.8 (2) sell or deliver a lower-potency hemp edible to a person who is visibly intoxicated;
2306		-	73.9 (3) sell or deliver cannabis flower, cannabis products, or hemp-derived consumer
2307		-	73.10products;
2308		-	73.11 (4) allow for the dispensing of lower-potency hemp edibles in vending machines; or
2309		-	73.12 (5) distribute or allow free samples of lower-potency hemp edibles except when the
2310		-	73.13business is licensed to permit on-site consumption and samples are consumed within its
2311		-	73.14licensed premises.
2312		-	73.15 EFFECTIVE DATE.This section is effective the day following final enactment.
2313		-	73.16Sec. 29. Minnesota Statutes 2024, section 342.46, subdivision 9, is amended to read:
2314		-	73.17 Subd. 9.Posting of notices.A lower-potency hemp edible retailer with a retail
2315		-	73.18endorsement must post all notices as provided in section 342.27, subdivision 6.
2316		-	73.19 EFFECTIVE DATE.This section is effective the day following final enactment.
2317		-	73.20Sec. 30. Minnesota Statutes 2024, section 342.62, subdivision 2, is amended to read:
2318		-	73.21 Subd. 2.Packaging requirements.(a) Except as provided in paragraph (b), all cannabis
2319		-	73.22flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products
2320		-	73.23sold to customers or patients must be:
2321		-	73.24 (1) prepackaged in packaging or a container that is child-resistant, tamper-evident, and
2322		-	73.25opaque; or
2323		-	73.26 (2) placed in packaging or a container that is plain, child-resistant, tamper-evident, and
2324		-	73.27opaque at the final point of sale to a customer.
2325		-	73.28 (b) The requirement that packaging be child-resistant does not apply to a lower-potency
2326		-	73.29hemp edible that is intended to be consumed as a beverage.
2327		-	73Article 3 Sec. 30.
2328		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 74.1 (c) If a cannabis product, lower-potency hemp edible, or a hemp-derived consumer
2329		-	74.2product is packaged in a manner that includes more than a single serving, each serving must
2330		-	74.3be indicated by scoring, wrapping, or other indicators designating the individual serving
2331		-	74.4size. If the item is a lower-potency hemp edible, serving indicators must meet the
2332		-	74.5requirements of section 342.46, subdivision 6, paragraph (b).
2333		-	74.6 (d) Notwithstanding paragraph (c), any edible cannabinoid products that are intended
2334		-	74.7to be combined with food or beverage products before consumption must indicate a single
2335		-	74.8serving using one of the following methods:
2336		-	74.9 (1) the product is packaged in individual servings;
2337		-	74.10 (2) the product indicates a single serving by scoring or use of another indicator that
2338		-	74.11appears on the product; or
2339		-	74.12 (3) the product is sold with a calibrated dropper, measuring spoon, or similar device for
2340		-	74.13measuring a single serving.
2341		-	74.14 (e) A package containing multiple servings of a lower-potency hemp edible that is not
2342		-	74.15intended to be consumed as a beverage must not contain:
2343		-	74.16 (1) more than 50 milligrams of delta-9 tetrahydrocannabinol;
2344		-	74.17 (2) more than 1,000 milligrams of cannabidiol, cannabigerol, cannabinol, or
2345		-	74.18cannabichromene:
2346		-	74.19 (3) more than the established limit of any other cannabinoid authorized by the office;
2347		-	74.20or
2348		-	74.21 (4) any combination of those cannabinoids that exceeds the identified amounts for the
2349		-	74.22applicable product category.
2350		-	74.23 (f) A single container containing a lower-potency hemp edible product that is intended
2351		-	74.24to be consumed as a beverage must not contain:
2352		-	74.25 (1) more than ten milligrams of delta-9 tetrahydrocannabinol;
2353		-	74.26 (2) more than 200 milligrams of cannabidiol, cannabigerol, cannabinol, or
2354		-	74.27cannabichromene;
2355		-	74.28 (3) more than the established limit of any other cannabinoid authorized by the office;
2356		-	74.29or
2357		-	74.30 (4) any combination of those cannabinoids that exceeds the identified amounts for the
2358		-	74.31applicable product category.
2359		-	74Article 3 Sec. 30.
2360		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 75.1 (d) (g) Edible cannabis products and lower-potency hemp edibles containing more than
2361		-	75.2a single serving must be prepackaged or placed at the final point of sale in packaging or a
2362		-	75.3container that is resealable.
2363		-	75.4 EFFECTIVE DATE.This section is effective the day following final enactment.
2364		-	75.5 Sec. 31. Minnesota Statutes 2024, section 342.63, subdivision 5, is amended to read:
2365		-	75.6 Subd. 5.Content of label; hemp-derived topical products.(a) All hemp-derived topical
2366		-	75.7products sold to customers must have affixed to the packaging or container of the product
2367		-	75.8a label that contains at least the following information:
2368		-	75.9 (1) the manufacturer name, location, phone number, and website;
2369		-	75.10 (2) the name and address of the independent, accredited laboratory used by the
2370		-	75.11manufacturer to test the product;
2371		-	75.12 (3) the net weight or volume of the product in the package or container;
2372		-	75.13 (4) the type of topical product;
2373		-	75.14 (5) the amount or percentage of cannabidiol, cannabigerol, or any other cannabinoid,
2374		-	75.15derivative, or extract of hemp, per serving and in total;
2375		-	75.16 (6) a list of ingredients;
2376		-	75.17 (7) a statement that the product does not claim to diagnose, treat, cure, or prevent any
2377		-	75.18disease and that the product has not been evaluated or approved by the United States Food
2378		-	75.19and Drug Administration, unless the product has been so approved; and
2379		-	75.20 (8) any other statements or information required by the office.
2380		-	75.21 (b) The information required in paragraph (a), clauses (1), (2), and (5), may be provided
2381		-	75.22through the use of a scannable barcode or matrix barcode that links to a page on a website
2382		-	75.23maintained by the manufacturer or distributor if that page contains all of the information
2383		-	75.24required by this subdivision.
2384		-	75.25Sec. 32. Minnesota Statutes 2024, section 342.65, is amended to read:
2385		-	75.26 342.65 INDUSTRIAL HEMP; PRODUCTS FOR SALE IN OTHER
2386		-	75.27JURISDICTIONS.
2387		-	75.28 (a) Nothing in this chapter shall limit the ability of a person licensed under chapter 18K
2388		-	75.29to grow industrial hemp for commercial or research purposes, process industrial hemp for
2389		-	75.30commercial purposes, sell hemp fiber products and hemp grain, manufacture hemp-derived
2390		-	75Article 3 Sec. 32.
2391		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 76.1topical products, or perform any other actions authorized by the commissioner of agriculture.
2392		-	76.2For purposes of this section, "processing" has the meaning given in section 18K.02,
2393		-	76.3subdivision 5, and does not include the process of creating artificially derived cannabinoids.
2394		-	76.4 (b) Nothing in this chapter prohibits a person who does not hold a license issued by the
2395		-	76.5office from manufacturing, packaging, labeling, and distributing products containing
2396		-	76.6cannabinoids derived from hemp that are not identified in paragraph (a) if:
2397		-	76.7 (1) the products are intended, distributed, and offered for sale only in jurisdictions other
2398		-	76.8than Minnesota; and
2399		-	76.9 (2) the products' packaging clearly states that the products are not for sale in Minnesota.
2400		-	76.10 (c) The office may take enforcement action as provided in section 342.19, subdivision
2401		-	76.116, if the office determines that the person:
2402		-	76.12 (1) sold or offered for sale in Minnesota any product containing cannabinoids that is not
2403		-	76.13identified in paragraph (a); or
2404		-	76.14 (2) manufactured, distributed, or stored any product containing cannabinoids derived
2405		-	76.15from hemp that is not identified in paragraph (a) with the intent that the product be offered
2406		-	76.16for sale in Minnesota.
2407		-	76.17Sec. 33. Minnesota Statutes 2024, section 342.66, subdivision 6, is amended to read:
2408		-	76.18 Subd. 6.Prohibitions.(a) A product sold to consumers under this section must not be
2409		-	76.19manufactured, marketed, distributed, or intended:
2410		-	76.20 (1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention
2411		-	76.21of disease in humans or other animals;
2412		-	76.22 (2) to affect the structure or any function of the bodies of humans or other animals;
2413		-	76.23 (3) to be consumed by combustion or vaporization of the product and inhalation of
2414		-	76.24smoke, aerosol, or vapor from the product;
2415		-	76.25 (4) to be consumed through chewing; or
2416		-	76.26 (5) to be consumed through injection or application to nonintact skin or a mucous
2417		-	76.27membrane or nonintact skin, except for products applied sublingually.
2418		-	76.28 (b) A product manufactured, marketed, distributed, or sold to consumers under this
2419		-	76.29section must not:
2420		-	76.30 (1) consist, in whole or in part, of any filthy, putrid, or decomposed substance;
2421		-	76Article 3 Sec. 33.
2422		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT 77.1 (2) have been produced, prepared, packed, or held under unsanitary conditions where
2423		-	77.2the product may have been rendered injurious to health, or where the product may have
2424		-	77.3been contaminated with filth;
2425		-	77.4 (3) be packaged in a container that is composed, in whole or in part, of any poisonous
2426		-	77.5or deleterious substance that may render the contents injurious to health;
2427		-	77.6 (4) contain any additives or excipients that have been found by the United States Food
2428		-	77.7and Drug Administration to be unsafe for human or animal consumption;
2429		-	77.8 (5) contain a cannabinoid or an amount or percentage of cannabinoids that is different
2430		-	77.9than the information stated on the label;
2431		-	77.10 (6) contain a cannabinoid, other than cannabidiol, cannabigerol, or a cannabinoid
2432		-	77.11approved by the office, in an amount that exceeds the standard established in subdivision
2433		-	77.122 3, paragraph (c); or
2434		-	77.13 (7) contain any contaminants for which testing is required by the office in amounts that
2435		-	77.14exceed the acceptable minimum standards established by the office.
2436		-	77.15 (c) No product containing any cannabinoid may be sold to any individual who is under
2437		-	77.1621 years of age.
2438		-	77Article 3 Sec. 33.
2439		-	REVISOR BD H1615-1HF1615 FIRST ENGROSSMENT Page.Ln 1.26MEDICAL CANNABIS.........................................................................ARTICLE 1
2440		-	Page.Ln 31.4CANNABIS BUSINESS LICENSING AND OPERATIONS...............ARTICLE 2
2441		-	Page.Ln 50.3HEMP BUSINESS REGULATIONS.....................................................ARTICLE 3
2442		-	1
2443		-	APPENDIX
2444		-	Article locations for H1615-1 152.22 DEFINITIONS.
2445		-	Subd. 2.Commissioner."Commissioner" means the commissioner of health.
2446		-	342.151 EMPLOYEES OF LICENSE HOLDERS.
2447		-	Subdivision 1.Definitions.For purposes of this section, a "license holder" includes a cannabis
2448		-	microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis manufacturer, cannabis
2449		-	retailer, cannabis wholesaler, cannabis transporter, cannabis testing facility, cannabis event organizer,
2450		-	cannabis delivery service, lower-potency hemp edible manufacturer, lower-potency hemp edible
2451		-	retailer, or medical cannabis combination business.
2452		-	342.36 CANNABIS TRANSPORTER OPERATIONS.
2453		-	Subd. 5.Randomized deliveries.A cannabis transporter shall ensure that all delivery times
2454		-	and routes are randomized.
2455		-	1R
2456		-	APPENDIX
2457		-	Repealed Minnesota Statutes: H1615-1
	29	+	NINETY-FOURTH SESSION 2.1 (6) be packaged in a way that resembles the trademarked, characteristic, or
	30	+	2.2product-specialized packaging of any commercially available food product; or
	31	+	2.3 (7) be packaged in a container that includes a statement, artwork, or design that could
	32	+	2.4reasonably mislead any person to believe that the package contains anything other than an
	33	+	2.5edible cannabinoid product.
	34	+	2.6 (c) An edible cannabinoid product must be prepackaged in packaging or a container that
	35	+	2.7is child-resistant, tamper-evident, and opaque or placed in packaging or a container that is
	36	+	2.8child-resistant, tamper-evident, and opaque at the final point of sale to a customer. The
	37	+	2.9requirement that packaging be child-resistant does not apply to an edible cannabinoid product
	38	+	2.10that is intended to be consumed as a beverage.
	39	+	2.11 (d) If an edible cannabinoid product, other than a product that is intended to be consumed
	40	+	2.12as a beverage, is intended for more than a single use or contains multiple servings, each
	41	+	2.13serving must be indicated by scoring, wrapping, or other indicators designating the individual
	42	+	2.14serving size that appear on the edible cannabinoid product. If it is not possible to indicate
	43	+	2.15a single serving by scoring or use of another indicator that appears on the product, the edible
	44	+	2.16cannabinoid product may not be packaged in a manner that includes more than a single
	45	+	2.17serving in each container, except that a calibrated dropper, measuring spoon, or similar
	46	+	2.18device for measuring a single serving, when sold with the product, may be used for any
	47	+	2.19edible cannabinoid products that are intended to be combined with food or beverage products
	48	+	2.20prior to consumption.
	49	+	2.21 (e) A label containing at least the following information must be affixed to the packaging
	50	+	2.22or container of all edible cannabinoid products sold to consumers:
	51	+	2.23 (1) the serving size;
	52	+	2.24 (2) the cannabinoid profile per serving and in total;
	53	+	2.25 (3) a list of ingredients, including identification of any major food allergens declared
	54	+	2.26by name; and
	55	+	2.27 (4) the following statement: "Keep this product out of reach of children."
	56	+	2.28 (f) An edible cannabinoid product must not contain more than five milligrams of any
	57	+	2.29tetrahydrocannabinol in a single serving, except that an edible cannabinoid product that is
	58	+	2.30intended to be consumed as a beverage may contain no more than ten milligrams of any
	59	+	2.31tetrahydrocannabinol in a single serving container. An edible cannabinoid product, other
	60	+	2.32than a product that is intended to be consumed as a beverage, may not contain more than a
	61	+	2.33total of 50 milligrams of any tetrahydrocannabinol per package. An edible cannabinoid
	62	+	2Section 1.
	63	+	REVISOR BD/MI 25-0413902/19/25 3.1product that is intended to be consumed as a beverage may not contain more than two
	64	+	3.2servings per container.
	65	+	3.3 (g) An edible cannabinoid product may contain delta-8 tetrahydrocannabinol or delta-9
	66	+	3.4tetrahydrocannabinol that is extracted from hemp plants or hemp plant parts or is an
	67	+	3.5artificially derived cannabinoid. Edible cannabinoid products are prohibited from containing
	68	+	3.6any other artificially derived cannabinoid, including but not limited to THC-P, THC-O, and
	69	+	3.7HHC, unless the office authorizes use of the artificially derived cannabinoid in edible
	70	+	3.8cannabinoid products. Edible cannabinoid products are prohibited from containing synthetic
	71	+	3.9cannabinoids.
	72	+	3.10 (h) Every person selling edible cannabinoid products to consumers, other than products
	73	+	3.11that are intended to be consumed as a beverage, must ensure that all edible cannabinoid
	74	+	3.12products are displayed behind a checkout counter where the public is not permitted or in a
	75	+	3.13locked case.
	76	+	3.14 Sec. 2. Minnesota Statutes 2024, section 342.01, subdivision 50, is amended to read:
	77	+	3.15 Subd. 50.Lower-potency hemp edible.(a) "Lower-potency hemp edible" means any
	78	+	3.16product that:
	79	+	3.17 (1) is intended to be eaten or consumed as a beverage by humans;
	80	+	3.18 (2) contains hemp concentrate or an artificially derived cannabinoid, in combination
	81	+	3.19with food ingredients;
	82	+	3.20 (3) is not a drug;
	83	+	3.21 (4) does not contain a cannabinoid derived from cannabis plants or cannabis flower;
	84	+	3.22 (5) is a type of product approved for sale by the office or is substantially similar to a
	85	+	3.23product approved by the office, including but not limited to products that resemble
	86	+	3.24nonalcoholic beverages, candy, and baked goods; and
	87	+	3.25 (6) meets either of the requirements in paragraph (b).
	88	+	3.26 (b) A lower-potency hemp edible includes:
	89	+	3.27 (1) a product that:
	90	+	3.28 (i) consists of servings that contain no more than five milligrams of delta-9
	91	+	3.29tetrahydrocannabinol; no more than 25 milligrams of cannabidiol, cannabigerol, cannabinol,
	92	+	3.30or cannabichromene; any other cannabinoid authorized by the office; or any combination
	93	+	3.31of those cannabinoids that does not exceed the identified amounts, except that a
	94	+	3Sec. 2.
	95	+	REVISOR BD/MI 25-0413902/19/25 4.1lower-potency hemp edible that is intended to be consumed as a beverage may contain no
	96	+	4.2more than ten milligrams of delta-9 tetrahydrocannabinol in a single serving container;
	97	+	4.3 (ii) does not contain more than a combined total of 0.5 milligrams of all other
	98	+	4.4cannabinoids per serving; and
	99	+	4.5 (iii) does not contain an artificially derived cannabinoid other than delta-9
	100	+	4.6tetrahydrocannabinol, except that a product may include artificially derived cannabinoids
	101	+	4.7created during the process of creating the delta-9 tetrahydrocannabinol that is added to the
	102	+	4.8product, if no artificially derived cannabinoid is added to the ingredient containing delta-9
	103	+	4.9tetrahydrocannabinol and the ratio of delta-9 tetrahydrocannabinol to all other artificially
	104	+	4.10derived cannabinoids is no less than 20 to one; or
	105	+	4.11 (2) a product that:
	106	+	4.12 (i) contains hemp concentrate processed or refined without increasing the percentage of
	107	+	4.13targeted cannabinoids or altering the ratio of cannabinoids in the extracts or resins of a hemp
	108	+	4.14plant or hemp plant parts beyond the variability generally recognized for the method used
	109	+	4.15for processing or refining or by an amount needed to reduce the total THC in the hemp
	110	+	4.16concentrate; and
	111	+	4.17 (ii) consists of servings that contain no more than five milligrams of total THC.
	112	+	4.18 Sec. 3. Minnesota Statutes 2024, section 342.46, subdivision 6, is amended to read:
	113	+	4.19 Subd. 6.Compliant products.(a) A lower-potency hemp edible retailer shall ensure
	114	+	4.20that all lower-potency hemp edibles offered for sale comply with the limits on the amount
	115	+	4.21and types of cannabinoids that a lower-potency hemp edible can contain, including but not
	116	+	4.22limited to the requirement that lower-potency hemp edibles:
	117	+	4.23 (1) consist of servings that contain no more than five milligrams of delta-9
	118	+	4.24tetrahydrocannabinol, no more than 25 milligrams of cannabidiol, no more than 25 milligrams
	119	+	4.25of cannabigerol, or any combination of those cannabinoids that does not exceed the identified
	120	+	4.26amounts, except that a lower-potency hemp edible that is intended to be consumed as a
	121	+	4.27beverage may contain no more than ten milligrams of delta-9 tetrahydrocannabinol in a
	122	+	4.28single serving container;
	123	+	4.29 (2) do not contain more than a combined total of 0.5 milligrams of all other cannabinoids
	124	+	4.30per serving; and
	125	+	4.31 (3) do not contain an artificially derived cannabinoid other than delta-9
	126	+	4.32tetrahydrocannabinol.
	127	+	4Sec. 3.
	128	+	REVISOR BD/MI 25-0413902/19/25 5.1 (b) If a lower-potency hemp edible is packaged in a manner that includes more than a
	129	+	5.2single serving, the lower-potency hemp edible must indicate each serving by scoring,
	130	+	5.3wrapping, or other indicators that appear on the lower-potency hemp edible designating the
	131	+	5.4individual serving size. If it is not possible to indicate a single serving by scoring or use of
	132	+	5.5another indicator that appears on the product, the lower-potency hemp edible may not be
	133	+	5.6packaged in a manner that includes more than a single serving in each container, except
	134	+	5.7that a calibrated dropper, measuring spoon, or similar device for measuring a single serving
	135	+	5.8may be used for any edible cannabinoid products that are intended to be combined with
	136	+	5.9food or beverage products prior to consumption. If the lower-potency hemp edible is meant
	137	+	5.10to be consumed as a beverage, the beverage container may not contain more than two
	138	+	5.11servings per container.
	139	+	5.12 (c) A single package containing multiple servings of a lower-potency hemp edible must
	140	+	5.13contain no more than 50 milligrams of delta-9 tetrahydrocannabinol, 250 milligrams of
	141	+	5.14cannabidiol, 250 milligrams of cannabigerol, or any combination of those cannabinoids that
	142	+	5.15does not exceed the identified amounts.
	143	+	5Sec. 3.
	144	+	REVISOR BD/MI 25-0413902/19/25